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Approximately 12% of all female sex workers (FSWs) around the world are living with HIV. FSWs 
confront heightened vulnerability not only to HIV infection, but also to social, economic and systemic 
barriers throughout the HIV care continuum and have sub-optimal engagement in HIV care. Despite 
this large burden of disease, there is very limited evidence on the HIV care experiences of FSWs living 
with HIV.  
Methods 
This study utilized a mixed methods approach to investigate FSWs’ experiences along the HIV care 
continuum. The first manuscript explored the experiences of 44 FSWs living with HIV throughout the 
HIV care continuum through in-depth interviews and focus group discussions in Santo Domingo, 
Dominican Republic. Informed by the findings from this thematic and narrative analysis, the second 
manuscript analyzed a quantitative, cross-sectional survey to describe the baseline HIV care 
continuum among 268 FSWs living with HIV in Santo Domingo. The manuscript then specifically 
examined factors associated with experience of antiretroviral therapy (ART) interruption using 
multiple logistic regression. The final manuscript determined the factors associated with retention in 
HIV care in the same study population using multiple measure of retention. 
Results 
FSWs living with HIV disengaged at each step of the HIV care continuum. Engagement in HIV care was 
not a static construct as participants continually negotiated engagement within a broader context of 
structural constraints and social conditions. FSWs described critical influences across multiple levels 
that either facilitated (re)engagement in HIV care or led to disengagement. Key individual-level 
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factors identified in the qualitative analysis were physical and mental health as post-diagnosis 
depression was often followed by disengagement in HIV care until declines in physical health were 
noted. Interpersonal factors centered on disclosure of HIV or FSW status and existent support. At the 
environmental level, participants frequently described systemic delays and the high costs of care, but 
good relationships with HIV care providers. Some experiences of discrimination within the clinic 
environment were, however, described. Lack of economic resources and pervasive HIV stigma and 
discrimination also complicated adherence to clinical appointments and ART.  
Within the quantitative sample, most participants linked to HIV care (92%), attended HIV services in 
the past six months (85%) and were initiated onto ART (78%), but discontinuation of treatment and 
irregular adherence to clinical appointments were frequent. A total of 36% of the participants ever 
initiated onto ART reported lifetime experience with an interruption of ART. The odds of ART 
interruption were 3.24 times higher among women who experienced sex work (SW)-related 
discrimination (95% confidence interval [CI]: 1.28, 8.20), 2.41 times higher among women who 
reported ever using any drug (95% CI: 1.09, 5.34) and 2.35 times higher among women who worked 
in a SW establishment (95% CI: 1.20, 4.60). Self-stigmatizing beliefs related to SW were associated 
with higher odds of interruption as each additional point on the SW self-stigma scale was associated 
with a 9% increase in the odds of ART interruption (95% CI: 1.02, 1.16). Positive perceptions of HIV 
providers were protective with each additional point on the perception of HIV provider scale 
associated with a 9% reduction in the odds of treatment interruption (95% CI: 0.85, 0.98).  
The final manuscript determined that a retention measure which included both attended and missed 
visits was the most appropriate measure of retention in this study population. A total of 37% of the 
women who attended HIV services in the past six months had missed at least one clinical 
appointment. The odds of being retained in HIV care were higher among participants with more 
positive perceptions of HIV service providers (adjusted relative odds [ARO]: 1.17; 95% confidence 
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interval [CI]: 01.09, 1.25). The odds of retention were lower among women who reported recent 
alcohol consumption (ARO: 0.50; 95% CI: 0.28, 0.92) and among women with self-stigmatizing beliefs 
related to SW (ARO: 0.93; 95% CI: 0.88, 0.98). 
Conclusions 
Individual, interpersonal, environmental and structural factors were important influences on 
engagement in HIV care among FSWs throughout the HIV care continuum. In addition to challenges 
faced by the general population living with HIV, FSWs confronted additional economic instability and 
the compounded stigma of being both HIV-infected and a FSW. Given the clear importance of 
improving engagement in HIV care to maximize individual and public health, there is an urgent need 
for multi-level interventions to help support FSWs throughout the HIV care continuum.  
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Chapter 1. Introduction 
Approximately 12% of all female sex workers (FSWs) around the world are living with HIV.1 
Despite this large burden of disease, there is very limited evidence on the HIV care experiences 
of these FSWs living with HIV.2,3 The research that does exist suggests that FSWs confront 
heightened vulnerability not only to HIV infection, but also to social, economic and systemic 
barriers throughout the HIV care continuum4-6 and have sub-optimal engagement in HIV care.3,7-
9 This is a critical health challenge as engagement in HIV care is associated with improved clinical 
outcomes, decreased transmission of HIV, reduced healthcare costs and increased access to 
antiretroviral therapy (ART).10,11 Access and adherence to ART, in turn, is strongly associated 
with reduced morbidity, mortality, and HIV transmission.12-14  
The clear benefits of ART have led to growing interest in the notion of “treatment as 
prevention” (TasP) with people living with HIV (PLHIV) in order to turn the tide of the HIV 
epidemic.14,15 TasP will have the most impact with PLHIV who aware of their HIV status and 
sexually active,16 such as FSWs diagnosed with HIV. In order to reap the individual and public 
benefits of ART among FSWs, we must first address the existent barriers to engagement in HIV 
care. Yet effective intervention requires an enhanced understanding of the facilitators and 
barriers to engagement.  
This dissertation contributes to the evidence on FSWs’ experiences along the HIV care 
continuum within Santo Domingo, Dominican Republic (DR). The study utilized a mixed methods 
approach to address the overall research question: What are FSWs’ experiences along the HIV 
care continuum? The study aims were to: 
1. Explore the experiences of FSWs living with HIV along the HIV care continuum 
2. Describe the HIV care continuum in FSWs living with HIV and examine the factors 




3. Determine the factors associated with retention in HIV care in FSWs living with HIV 
In order to meet these aims, this dissertation includes eight chapters which each describe 
various facets of FSWs’ experiences along the HIV care continuum. The second chapter 
describes the current evidence on engagement in HIV care and the HIV care continuum, the 
experiences of FSWs and HIV, and the state of the HIV epidemic and services within the DR. 
Based on this foundation, the third chapter describes the mixed methods that were used in this 
dissertation to add to the existent body of evidence. 
 
The fourth, fifth and sixth chapters present the new results that address the aims of this 
dissertation. Chapter four describes findings from a qualitative exploration of the experiences of 
44 FSWs living with HIV throughout the HIV care continuum. This analysis demonstrated how 
FSWs experienced critical factors at the individual, interpersonal, environmental and structural 
levels that either facilitated (re)engagement in HIV care or led to disengagement throughout the 
HIV care continuum. Figure 1.1 depicts a modified version of the emergent framework from this 
analysis and shows how each study aim relates to the broader dissertation question. Informed 
by the findings from the first qualitative aim, Chapter five presents the findings related to the 
quantitative second aim, an evaluation of the baseline HIV care continuum among FSWs living 
with HIV. It then specifically examines the relationship between the key factors identified in the 
qualitative analysis and experience of ART interruption, a form of disengagement. Chapter six 
then explores some of the complexity in measurement of engagement in HIV care and addresses 
aim three by determining the factors associated with retention in HIV care. The seventh chapter 
provides a discussion of the mixed methods results and the eighth chapter concludes by 




Figure 1.1 Organizing framework for dissertation on the experiences of FSWs along the  







Chapter 2. Relevant Literature 
Engagement in HIV care has considerable societal and individual benefits including improved 
individual health outcomes, reduced transmission of HIV, lower healthcare costs and higher 
access to ART.10,11 The health benefits of early initiation onto ART, such as reduced morbidity 
and mortality, are well-established.12 There is now conclusive evidence that ART can also 
substantially decrease the likelihood that an individual will transmit HIV to others. ART reduces 
the spread of HIV by suppressing HIV replication which decreases the concentration of HIV-1 
ribonucleic acid (hereafter referred to as HIV viral load) within an individual’s blood.14,17 The HIV 
Prevention Trials Network (HPTN) 052 study demonstrated that immediate initiation onto ART 
led to a 96% reduction in HIV transmissions and a 41% reduction in clinical endpoints such as 
extrapulmonary tuberculosis (TB).13  
The success of the HPTN 052 study has led to growing interest in the notion of using HIV 
treatment as a mechanism for prevention of HIV transmission with PLHIV, commonly referred to 
as treatment as prevention or TasP.14,15,18 Subsequent research has supported the findings of 
HPTN 052 and has demonstrated that ART is associated with reduced morbidity, mortality and 
HIV transmission in diverse populations.14,18-20 TasP is most relevant for individuals who are 
currently living with HIV, aware of their HIV status and engaging in HIV transmission-related 
behaviors such as sexual intercourse or injection drug use.16 This provides clear evidence of the 
importance of initiation and retention on ART, particularly with known HIV-infected individuals 
that frequently engage in sexual activity, such as FSWs.  
In order for TasP to be effective and to obtain optimal health outcomes, HIV services must be 
physically and culturally accessible and acceptable, particularly for marginalized populations. 
Holtgrave and colleagues highlighted that the potential of TasP will not be achieved without 




that specifically target PLHIV must also foster environments that support the overall wellbeing 
and human rights of PLHIV.21 These positive health, dignity and prevention (PHDP) interventions 
often address the physical and mental health and agency of PLHIV, along with the prevention of 
HIV transmission to others.22 The overarching goal of PHDP efforts is to "improve the dignity, 
quality, and length of life of people living with HIV; which, if achieved will, in turn, have a 
beneficial impact on their partners, families, and communities, including reducing the likelihood 
of new infections".21  
Despite the considerable individual and societal health benefits of engagement in HIV care, 
global access to ART is sub-optimal. There has been a dramatic increase in the number of 
individuals receiving ART in developing countries, but coverage levels are still low and barriers to 
ART persist. In 2009, 5,254,000 people in low- and middle-income countries were receiving ART, 
representing a 13-fold increase since 2003, yet coverage of those with CD4 counts below 350 
cells/ mm³ was only 36%.23 This demonstrates the importance of research on current access and 
barriers to HIV care and ART, particularly within vulnerable populations. It also highlights the 
need for guidance to inform interventions that address the multiple levels of barriers confronted 





HIV care continuum 
There has been growing interest in and attention to the HIV care continuum24,25 as a mechanism 
for understanding the HIV epidemic and identifying key unmet needs. The continuum, 
previously described as the HIV treatment cascade and spectrum of engagement in HIV 
care,24,26,27 delineates the steps within the successful provision of HIV services for PLHIV. The 
steps along this pathway include HIV testing, HIV diagnosis, linkage to HIV services, assessment 
of eligibility for ART, retention in pre-ART care, pre-ART patient preparation, ART initiation, 
retention in ART care, adherence to ART, and HIV viral suppression,28,29 as depicted in Figure 2.1.  
Figure 2.1 The HIV care continuum from HIV infection to viral suppression on antiretroviral 
therapy 
 
Patients temporarily or permanently disengage at each of the steps along this dynamic 
pathway28,30 and often cycle in an out of care,31-33 as shown by the dashes leading away from 




barriers to engagement led researchers to conclude that the continuum “often operated more 
like an obstacle course than a smoothly paved road.”34 Some of these challenges include late 
HIV diagnosis, suboptimal linkage to and retention in HIV care, low use of ART, and poor 
adherence to ART.26 
The losses along the HIV care continuum gained considerable national and global attention 
when a study by Marks and colleagues found that only 28% of PLHIV in the United States (US) 
have reached viral suppression with drop off and delays at each step.35 Another study of 
establishment, retention and loss to follow-up (LTFU) in HIV care among 22,984 patients in the 
US found that 21.7% of patients did not establish long-term care, defined as more than 6 
months of outpatient care visits, 57.4% of those patients who established care were not 
consistently retained in care and 34.9% of patients were LTFU.11 A 2011 review of published 
literature by Gardner and colleagues determined that only 79% of PLHIV in the US were aware 
of their HIV status, of which 75% linked to HIV care within 6-12 months after diagnosis. Further, 
approximately 50% of people with an HIV diagnosis in the US were not retained in care. The 
authors estimated that only 25% of in-care PLHIV who should have received ART actually 
obtained it and just 55% of these individuals had adequate adherence to ART.26 
The depiction of the HIV care continuum has now been applied to describe the HIV epidemic in 
diverse settings. The depiction provides a striking representation of the poor state of 
engagement in HIV care36 in the US26,37 and in global settings.25,38-40 A recent cohort study of 
engagement in HIV care in India found that there was high attrition during pre-ART care and that 
only 31% of the participants with an HIV diagnosis had reached  viral suppression, despite the 
free provision of ART services and active tracing of patients LTFU.38 Similarly, a longitudinal 
study of engagement in British Columbia, Canada documented high attrition throughout the HIV 




By describing losses at each step, the continuum highlights challenges that compromise the 
effectiveness of HIV prevention and care strategies. It can also serve as an important mechanism 
to mobilize change and foster improvements in HIV services.34 The predominantly quantitative 
depiction of the continuum does not, however, address the processes or pathways from one 
step to the next or provide insight into patients’ perspectives.24 This underscores the utility of 
qualitative exploration of the barriers confronted by PLHIV throughout the continuum.34 Despite 
critiques that discussion of the HIV care continuum has been largely constructed from the 
perspective of health care providers,24 the continuum remainsa useful way to determine the 
state of treatment and prevention41 within specific sub-populations.42-44 The continuum has not, 
however, been applied to describe the HIV epidemic within FSWs. There is a clear need for 
additional research on the pathways and barriers faced by PLHIV throughout the HIV care 
continuum33,34 and on facilitators of engagement in HIV care, particularly within groups most 





Measuring engagement in HIV care 
There is growing interest in patients’ engagement (comprised of linkage, retention and re-
engagement) in HIV care, but no clear “gold standard” exists for its measurement.30,45 Linkage to 
care is relatively easier to measure as the binary construct of having ever attended HIV services, 
but measurement of retention is more complex.30 Retention in HIV care has been defined as 
“the consistency of service utilization after the initial care period.”11 It has been measured in 
many ways, including through missed visits, visit adherence, and treatment gaps. These 
measures are all calculated either through missed or kept visits with primary HIV medical 
providers.30,45 A 2012 study by Mugavero and colleagues evaluated six different commonly used 
retention measurements and their associations with one-another and with HIV viral suppression 
among in-care patients in the US. The six measures were:  
1. Count of missed visits (not canceled in advance) with primary HIV medical provider 
2. Dichotomous any missed visits (not canceled in advance) with primary HIV medical 
provider 
3. Proportion of visit adherence with primary HIV medical provider (defined as the 
proportion of kept visits of total scheduled visits) 
4. Four-month visit constancy (number of four-month-long intervals in a year during which 
the patient had at least one kept visit with primary HIV medical provider) 
5. Six-month gap (dichotomous measure of whether 189 or more days elapsed in between 
kept visits with primary HIV medical provider)  
6. Human Resources and Services Administration HIV/AIDS Bureau (HRSA HAB) measure 
(dichotomous measure of whether there were at least two kept visits with primary HIV 
medical provider that were at least 90 days apart within the year)30,45  
The authors determined that all of the measures based on missed visits were highly correlated 
with one-another (Spearman correlation coefficients were 0.83–0.85), as were the measures 
based on kept visits (Spearman correlation coefficients 0.72–0.77). There was, however, 
considerable variation across the measures in their categorization of patients as retained. 
Retention was lowest when based on perfect visit adherence and highest using the HRSA HAB 




associated with HIV virologic suppression, with varying sensitivity and specificity. Based on these 
findings, the authors concluded that there is no one best measure of retention in care. Instead, 
measures should be selected based on the available data, the question of interest, and the study 
rationale. The authors also suggested that it may be beneficial to use multiple retention 
measures within one study, particularly one based on missed visits and another based on kept 
visits.45 An earlier study emphasized that selection of the appropriate measure of retention 
should also be based on clinic scheduling practices, duration of observation and study 





Barriers to engagement in HIV care 
There is a growing body of evidence on the barriers to engagement in HIV care faced by the 
general PLHIV population. A recent systematic review that compared studies on factors 
associated with HIV testing, ART initiation and ART adherence from low and high income 
countries found that most studies in low income countries highlighted socioeconomic and 
health system barriers to HIV care, whereas studies from high income countries predominantly 
focused on medical and psychosocial factors. Stigma and discrimination, substance use, 
depression, self-efficacy and social support were salient influences across settings.46 Some of the 
most frequently described barriers to HIV care noted in the literature by PLHIV at the individual-
level include mental distress and feeling healthy.3,24,47,48 Examples of interpersonal barriers were 
lack of HIV status disclosure and insufficient social support.48 Environmental barriers included 
inconvenient clinic hours and location, long lines within clinics, lack of available appointments, 
perceived low quality of HIV services, and disrespectful treatment from HIV care providers or 
staff.49-52 Finally, structural barriers included poverty, gender inequity, and HIV-related stigma 
and discrimination.49,50  
HIV-related stigma and discrimination are some of the most pervasive barriers to engagement in 
HIV care. Stigma is a social process that reinforces differences and perpetuates existent 
inequities.53 There are multiple forms of stigma, including enacted stigma (harassment, 
discrimination, or unequal access to conditions or opportunities) and internalized stigma 
(acceptance of perpetuated negative messages about oneself and individuals like oneself which 
results in negative attitudes towards self and community) related to HIV.54,55 This process 
manifests in diverse ways such as loss of social status, discriminatory treatment, and social 
isolation.56 Stigma prevents engagement in HIV care in multiple ways, including delaying HIV 




tangible support, increasing rejection of PLHIV by sexual partners, family and social networks, 
and generating reluctance to be seen taking treatment or attending an HIV clinic.49,57,58 
Internalized stigma can also be detrimental to physical and mental health.54,59 Rather than acting 
in isolation, there is a layering or intersection of HIV-related stigma and stigmas associated with 
other identities such as sexism, racism and homophopia.53,56 Different forms of stigma may also 
differentially impact engagement in HIV care. For example, a study of FSWs in Russia found that 
HIV-related stigma was associated with lower HIV testing, but sex work (SW)-related stigma was 
associated with higher HIV testing.5 Thus, stigma and discrimination can affect access to health 





Model of access to health services 
Given the low rates of engagement in HIV care across the HIV care continuum, it is important to 
understand some of the relevant theory related to use of medical services. One of the 
predominant models used to characterize and predict utilization of medical care is Andersen’s 
Behavioral Model of Access to Medical Care.60-62 This model was developed in the 1960s to 
define, measure and promote equitable access to health services.60 The original model 
described health service use at the family level as a function of predisposition to use services, 
factors that enable or impede use and the level of need for care.61 Andersen and colleagues 
conceptualized the model as both predictive and explanatory of health services use.60 The 
model has been revisited and revised over the past decades by Andersen and colleagues to 
focus on the individual as the unit of analysis, to consider the influence of the health care 
system on access, to focus on measures of health services use and consumer satisfaction, to 
highlight the predisposing factors for vulnerable populations and to include feedback loops in 
which health service use affects predisposing factors and perceived need.60,62-64 
The central constructs of the model are predisposing characteristics, enabling resources, and the 
health need of individuals.60,61 Predisposing characteristics- the propensity to use services- are 
comprised of demographic factors, social structures such as household composition, health of 
the physical environment and health beliefs related to the use of health services. Enabling 
resources are the personal, family and community resources available to use health services. 
These include both the accessibility of health services and an individual’s ability to use these 
services. Key components include income, health insurance, travel and waiting times. While 
named “enablers”, this construct includes variables that are more generally considered to be 
barriers to health services such as distance to clinic. This construct also includes the social and 




peer navigators. The final construct is health need. This includes an individual’s perception of 
his/her own health state and professional judgment by medical practitioners about an 
individual’s need for care.60,63,64 
Andersen and colleagues described four forms of access to health services: potential access, 
realized access, equitable access and inequitable access. Potential access exists when there are 
enabling resources. Realized access is when an individual actually uses health services. Equitable 
access is when most of the variance in health service use is explained by demographic and need 
factors. Inequitable access is when predisposing characteristics and enabling resources account 
for most of the variance in who receives medical care.60,61 Rather than serving as a falsifiable 
theory, inherent in the model is the understanding that different factors influence access to 
health services and that the composition of these factors is indicative of the underlying level and 
equality of access within a given population. For example, the model is not disproven if 
predisposing and enabling factors are not significantly associated with access to care. Rather, 
this situation would be indicative of more equitable access to care. 
Andersen and colleagues were interested in describing current health care access, but also in 
informing interventions to improve access. In order to do so, they considered the mutability of 
each of the constructs because a construct must be changeable in order to promote better 
access.65 Demographic variables and social structures are of low mutability because they are 
very difficult or impossible to alter; health beliefs are of medium mutability since they can 
sometimes be changed; and enabling resources are of high mutability because they can be 
addressed by interventions. Perceived and evaluated need for health care may also be 
influenced.60 Thus, interventions may be most effective in influencing health care access when 
they target the enabling factors since these are more malleable. In the past fifty years, the 




care in different racial/ethnic groups,66 HIV testing among black men,67 HIV primary care use in 
recently diagnosed individuals68 and access to ART in vulnerable groups.62 
The Andersen model has evolved over time as researchers apply it to different populations and 
one of its most recent iterations is the Behavioral Model for Vulnerable Populations. This model 
was developed by Gelberg, Andersen and colleagues in 2000.62,69 This rendition focuses on the 
ways in which the individual level predisposing factors, enabling resources and health need are 
influenced by membership in vulnerable groups. Constructs within the vulnerable population 
version of the model have been found to be significantly associated with access to ART and 
primary care use in studies of PLHIV in the United States.62,68 A randomized controlled trial of 
primary care use among PLHIV in the US compared attendance at HIV care of individuals 
recently diagnosed with HIV in those who received active case management with those who 
received passive referral.68 The study found that ethnicity, gender, education, IDU status, testing 
positive for Hepatitis, HIV-related symptoms in the past six months, having medical insurance 
and receiving case management were significantly associated with having been seen by an HIV 
service provider in the past six months. The authors concluded that active case management 
significantly improved linkage to HIV care within vulnerable populations, but there was no 
evidence of the impact of the intervention on adherence to ART. 
The Andersen model has also been applied to look at access to ART in the US and within 
developing countries. A study of access to ART in 1996 in vulnerable groups in the US62 found 
that individuals in the greatest need of ART, as defined by CD4 count, had the highest access to 
ART. Predisposing factors and enabling factors were, however, also important which was 
indicative of some inequitable access for vulnerable populations such as women, African 
Americans, Hispanics, injection drug users and the less educated. In the final model, the authors 




first HIV test, and waits for medical appointments were significantly associated with access to 
ART.62 
A systematic review of access to ART in developing countries also used the Andersen model to 
explore access. The authors determined that enabling factors such as lack of knowledge of ART, 
perceived high cost of ART, stigma, and lack of financial means were important barriers to ART 
across the 19 included articles. Important predisposing factors were fears of treatment side-
effects and spousal permission to initiate ART. Health system barriers to access to ART were 
distance to health facilities, lack of systemic coordination and the limited involvement of 




Adherence to ART 
Once an individual is engaged in HIV care and initiated onto ART, it is particularly important that 
they are adherent to treatment in order to maximize individual health benefits, reduce the 
likelihood of HIV transmission and prevent development of drug resistance. Factors that 
facilitate the development of drug resistance include the nature of the virus itself, the need for 
high adherence to lifelong treatment, irregular access to ART due to stock-outs, and single dose 
prevention of mother-to-child transmission strategies.70 This transmitted drug resistance 
reduces treatment options and can lead to diminished patient outcomes. Ultimately, it can also 
render national HIV treatment program less effective.70-72 There are serious concerns that the 
prevalence of treatment-resistant strains of HIV is already high and will continue to increase 
world-wide.72 The highest increase in prevalence of resistance that was noted in a recent, global 
systematic review was found in East Africa where the increase in the prevalence of resistance 
was 29% a year since rollout of treatment.72 Within Latin America and the Caribbean, an 
estimated 7.6% of individuals had resistance to one or more drugs by 8-9 years after the 
initiation of national ART programs.72  
There are diverse reasons why patients are not adherent to ART. Some factors that have been 
documented in high income countries are depression, social instability, substance abuse, and 
low literacy.73,74 Factors identified in low income countries include lack of open communication 
with health providers and insufficient access to transportation, food and ART.51,74,75 For example, 
a study of barriers to adherence to ART in FSWs in Rwanda highlighted the role of structural 
barriers such as lack of food and imprisonment in inhibiting ART adherence.9  
There has been very limited research on the barriers to ART adherence faced by PLHIV within 
the Caribbean74 and no known study has specifically looked at barriers to ART adherence among 




population in the DR determined the risk factors for non-adherence to ART through a cross-
sectional survey of 300 patients in two clinics. Patients’ one-month ART adherence was 
dichotomized as optimal if they self-reported greater than 95% adherence or suboptimal if less 
than 95% adherence. The study found that 24% of participants reported suboptimal adherence 
in the past month. Suboptimal adherence was significantly associated with heavy alcohol use, 
having children, and reporting perceptions that they had less social support in general and less 
social support specifically related to adherence. Patients also frequently indicated that they ran 
out of medications or were away from home. The authors suggested the use of adherence 
support by community health workers or treatment partners in order to facilitate improved 
adherence.74 Treatment partners serve several important functions such as “(1) encouraging 





FSWs and HIV/AIDS 
There is substantial interest in FSWs within the context of HIV due to their heightened 
vulnerability and their role within the broader epidemic.77 FSWs have significantly higher HIV 
prevalence than the general population in countries around the world.1,78 A meta-analysis of 
99,878 FSWs included in 102 studies from around the world found that FSWs have 13.5 times 
higher odds of HIV infection than other women of reproductive age.1 For example, the HIV 
prevalence of FSWs in the DR is between 3.3% and 8.4%, depending on geographic location.79 
This is much higher than the HIV prevalence in the general population of 0.7%.80 FSWs are at 
higher risk of HIV infection for a variety of reasons, including their elevated numbers of 
concurrent sexual partners, their high prevalence of sexually transmitted infections (STIs), and 
the confluence of SW and injection drug use in some settings.1 FSWs also confront structural 
barriers to HIV testing, care and treatment1 such as stigmatization and discrimination within 
health services.81 
 FSWs’ key role in the HIV pandemic has led to various targeted efforts to try to prevent HIV 
infection among FSWs. 82 These interventions to reduce HIV incidence in FSWs are now a 
component of some national and international efforts to reduce HIV transmission.83-85 
Interventions that have proven to be effective include peer education, condom distribution and 
promotion, structural interventions, and community mobilization.1,77,82,85-93 These interventions 
have been effective in increasing protective behaviors among FSWs and their clients.85 A 2012 
review indicated that over 80% of FSWs reported condom use at last sex with clients in 44 of the 
87 countries where data were available.1 Despite the effectiveness of some HIV prevention 
interventions with FSWs, less than 50% of SWs are able to access these HIV prevention 
programs and these programs do not meet the needs of the growing population of FSWs who 




FSWs living with HIV 
There is a substantial body of evidence on HIV prevention with FSWs, but there has been 
relatively little research on FSWs who are already HIV-infected,2,3 highlighting a critical gap in 
the literature. The limited evidence suggests that FSWs experience multiple barriers to HIV care 
linkage and retention4-6 at the individual, interpersonal, and health system/programmatic levels, 
along with stigma and discrimination.3,7,8,94,95 These barriers are largely the same as those 
described within the general PLHIV population, but FSWs living with HIV also confront some 
unique barriers. These include layers of stigma and discrimination related to each of their 
stigmatized identities which inhibit engagement throughout the HIV care continuum.2,3,7,8,53,56,96-
98 No known study has, however, looked at the intersection of HIV and FSW stigma within the 
Caribbean or the influence of each form of enacted and internalized stigma throughout the HIV 
care continuum. 
Engagement of FSWs in HIV care 
Rather than focusing on the lived social, medical or behavioral experiences of FSWs living with 
HIV, most studies with this population either are highly biomedical in nature or describe factors 
associated with HIV-positive status among FSWs (unpublished results). There are limited studies 
on the experiences of FSWs in HIV care. One study of linkage to care, sexual behavior and 
psychosocial experiences among 141 FSWs recently diagnosed with HIV in Rwanda found that 
85% of participants had enrolled in HIV care and 48% had initiated ART within approximately 
two years after diagnosis. Women were significantly less likely to have enrolled in care if they 
were breastfeeding, had a known HIV-infected sexual partner or reported condom use at last 
sexual act. The most frequently mentioned barriers to ART adherence were forgetting, lack of 
food, and interruptions due to imprisonment or hospitalization.9 Participants in this study were, 




generalizability of this study to a non-research setting may be limited. Of concern, separate 
studies of treatment outcomes in FSWs living with HIV in Burkina Faso and Benin have noted 
worse virologic response to ART, higher rates of treatment failure, and higher mortality than 
other women living with HIV.99,100 The authors hypothesized that the lower treatment response 
may have been related to lower adherence to ART and higher alcohol use among the FSWs.99 An 
analysis of mortality among cohort of FSWs in India also found high HIV-attributable mortality 
among FSWs, despite the fact that most of the participants had attended health services and 
disclosed their HIV status to their families. Barriers to health services among women who had 
not attended health services were distrust of healthcare providers, lack of knowledge of clinic 
locations, perceived cost of treatment, and lack of social support for treatment.94 
There have also been various qualitative studies on the experiences of FSWs living with HIV. One 
study found that the main barriers to service access for 19 FSWs in India were at the 
family/social, health care system/programmatic and individual levels.7 A qualitative study with 
FSWs, transgender women (TW), and men who have sex with men (MSM) in India also described 
important personal, interpersonal and structural barriers to utilizing HIV services.96 A different 
study of access to HIV care among FSWs in Zimbabwe highlighted the important role of 
providers in participants’ engagement. These participants also noted concerns related to cost of 
some HIV services, lack of food, and stigma.3 Stigma and discrimination against vulnerable 
populations, including FSWs, within health care systems were also described in a recent review 
article.6 The review concluded that“[h]owever defined, what is shared by [most at risk 
populations- including FSWs] nearly universally is high vulnerability to HIV infection and low 
access to HIV services."6 There is a clear need for further research on and interventions to 
address engagement in HIV care among FSWs, including in countries with concentrated HIV 




HIV/AIDS and the Dominican Republic  
The HIV/AIDS pandemic in the DR is shaped by diverse external and internal factors, including its 
porous border with Haiti, frequent emigration and immigration of Dominicans between the US 
and the DR, and its reputation as a sex tourism destination.101-103 The DR is relatively better-
resourced than other low and middle income countries, but there is still considerable poverty74 
and 33.2% of Dominicans lived below the poverty line of US$94.20 a month in 2010.104 Estimates 
of the HIV prevalence in the DR have varied, but recent estimates by UNAIDS indicate that the 
epidemic has stabilized at 0.7% with approximately 44,000 PLHIV in the country.80 This is lower 
than projections made in the early 2000s when some predicted that the epidemic might 
continue to expand considerably.105 This stabilization has been partially attributed to the 
“proactive response” of non-governmental organizations (NGOs) early on within the 
epidemic.106  
Despite these successes, the Caribbean remains one of the most affected regions with an HIV 
prevalence second only to sub-Saharan Africa. The island of Hispaniola, comprised of the DR and 
Haiti, accounts for nearly three-quarters of HIV infections within the Caribbean.57 There is also 
evidence of a considerable double burden of TB and HIV on the island: 95% of co-infections in a 
seven country Caribbean study occurred in either the DR or Haiti and there was a 4% co-
infection prevalence in the DR.107 The predominant subtype of HIV in the DR and in the 
Caribbean is subtype B. This is notable as the Caribbean is the only subtype B region that has 
predominantly heterosexual transmission.108  
The burden of HIV varies considerably across populations and geographic regions in the DR.106 
Prevalence is elevated among FSWs, MSM and Haitian immigrants who live in the former 
sugarcane plantations.105 HIV in the DR is predominantly passed through heterosexual sexual 




through sex with other men and that this mechanism for transmission has been 
underreported.105 HIV prevalence has declined in most groups, other than MSM. For example, 
HIV prevalence in FSWs in La Romana is estimated to have declined from 12.5% in 1996 to 4.1% 
in 2006. In Santo Domingo, HIV prevalence in FSWs has decreased from a median of 5% in 1991 
to 3% in 2006.105,109 A recent analysis of the HIV epidemic trends in the DR attributed the overall 
decline in HIV prevalence to increases in condom use and other sexual behavior changes within 
the country.105  
The DR has developed laws to protect PLHIV, but discrimination against PLHIV remains 
problematic. The DR law related to HIV/AIDS enshrines the human rights and dignity of PLHIV.110 
The law states that PLHIV have the right to health care, to information related to their health, to 
work and to not be discriminated against. Despite these laws, PLHIV within the DR frequently 
report that they have been refused employment due to their HIV status.57 For example, multiple 
qualitative studies in the DR have noted the use of HIV testing during eligibility screening for 
employment.97,103 A recent survey reported in the 2013 UNAIDS report on the global HIV 
epidemic found that 10% of respondents from the DR indicated having been refused 
employment and 8% were denied health and/or dental services due to their HIV status. PLHIV 
also still confronted restrictions on their entry, stay or residence within the DR as of 2013.111  
ART and the Dominican Republic 
The DR began the large-scale provision of ART in governmental and non-governmental clinics in 
2003.70,107 ART is supplied for free to those who are eligible, defined as having a CD4 count less 
than 350 cells/mm³. Provision of ART is funded by the Global Fund to Fight AIDS, Tuberculosis 
and Malaria, the World Bank and the Dominican Ministry of Health and Welfare.107 




an estimated 14,000 adults were on ART by the end of 2009.107 As of 2012, 21,138 people were 
currently receiving ART, but more than 2,500 individuals with AIDS-defining illness did not have 
access to this treatment. The estimated ART coverage based on the WHO 2010 guidelines was 
78%57,112 The first line regimen in the national program is two nucleoside reverse transcriptase 
inhibitors (NRTI) and one non-nucleoside reverse transcriptase inhibitors (NNRTI). The second-
line regimen is comprised of NRTIs and protease inhibitors.70 A recent study of patients in two 
clinics in the DR, including one in Santo Domingo, found that most patients (50%) were on 
zidovudine (an NRTI), lamivudine (an NRTI), and nevirapine (an NNRTI).74 
It has now been established that ART can be effectively delivered in low and middle-income 
countries, but some challenges remain. For example, patient mortality in the first six months on 
treatment is higher in these countries than in more resourced settings.107 A recent analysis of 
patient outcomes in ART-naïve patients in cohorts in seven Latin American countries 
documented an average early mortality rate of 20.9 deaths per 100 person years in the first 
three months, a rate that is comparable to other low- and middle-income countries.107 The DR, 
however, had the highest early mortality of all the included countries with 32.4 deaths per 100 
person-years. High rates of LTFU were also noted; the 1,207 person Dominican cohort was 
followed up for a median of 31 months during which time 13% of patients were LTFU and 15% 
died. The study also documented very low median baseline hemoglobin (11.1 grams per 
deciliter in females and 12.0 grams per deciliter in males) and CD4 count (96 cells/ mm³) in 
patients. A total of 51% of patients with known CD4 count at baseline visit had CD4 counts less 
than 100 cells/ mm³ and 45% had Stage III or IV illness. Overall, the regional baseline health 
indicators were similar to what has been documented in other lower income countries and are 
much lower than those found within Europe and North America. The authors highlighted the 




ART enrolment and adoption of earlier initiation onto ART.107 This need is likely particularly 
acute within marginalized populations such as FSWs. A different study conducted in 2011 in La 
Romana, DR also found that participants initiated ART quite late. The mean CD4 count at the 
time of ART initiation was 160 cells/ mm³.73 
A cohort study conducted from 2007-2010 in the Instituto Dermatológico y Cirugía de Piel (IDCP) 
HIV clinic in Santo Domingo determined that 8 of the 103 (8.8%) treatment-naïve adults in the 
study were infected with HIV that had drug resistant mutations, with no clear risk factors.70 It is 
notable that this clinic is regularly attended by many FSWs described within this dissertation. 
One recent study has, however, demonstrated the effectiveness of targeted individual 
counseling concurrent with ART initiation in significantly increasing appointment attendance 
and treatment response in PLHIV in the DR. Barriers in the form of transportation and work 
schedule conflicts, however, persisted.73 There is growing evidence related to the HIV care 
continuum in FSWs living with HIV in the DR, but there is a clear need for additional research to 





Chapter 3. Methods 
The purpose of this mixed methods dissertation was to explore the experiences of FSWs living 
with HIV along the HIV care continuum in the DR. This study employed an exploratory 
sequential, mixed methods design in order to address this goal. An exploratory sequential study 
is one in which researchers first explore a topic qualitatively and then use findings from the 
analysis of these qualitative data to inform a quantitative phase. This design is often used in the 
development and use of a survey instrument.113 The rationale for this exploratory sequential 
design was to first qualitatively explore baseline experiences among a small group of FSWs living 
with HIV and then to determine how the qualitative findings relate to a larger group of FSWs 
within Santo Domingo.  
Research Methods 






Table 3.1 Overview of study aims and design 
Aim Methods  Key Independent  





FSWs living with 




with FSWs living with 
HIV (n=20)  
Three focus group 
discussions (FGDs) 
with FSWs living with 
HIV (n=24) 
• Participant experiences along the HIV care 
continuum from HIV diagnosis to time of 
interview  
• Barriers to (re)engagement in HIV care  
• Enablers of (re)engagement in HIV care 
 
Describe the HIV 
care continuum in 
FSWs living with 





FSWs living with 
HIV 
Baseline survey with 
FSWs living with HIV 




characteristics (e.g. age, 
household composition, 
income) 
• Clinical experiences (e.g. 
perception of health 
status, health providers) 








with retention in 
HIV care in FSWs 
living with HIV  
Baseline survey with 
FSWs living with HIV 




characteristics (e.g. age, 
household composition) 
• Enabling factors (e.g. 
perceived quality of HIV 
services, experience of 
discrimination in the 
clinic, cost of 
transportation to clinic) 
• Perceived and evaluated 
health need 
• Vulnerability (duration of 
SW, self-stigmatizing 
beliefs) 
Retention in HIV 








Qualitative Phase Research Methods  
The qualitative phase of the study addressed aim one, to explore the experiences with HIV care 
of FSWs living with HIV. This aim was addressed through formative qualitative interviews and 
FGDs with FSWs living with HIV in Santo Domingo, DR. This research was originally conducted  to 
inform the design of the Abriendo Puertas intervention (discussed below). This formative 
research included in-depth interviews (IDIs) with 20 FSWs living with HIV and three FGDs with an 
additional 24 FSWs living with HIV. Data were collected between September 2011 and February 
2012 by the Dominican HIV Vaccine and Research Unit (HVRU). The interviews and FGDs with 
FSWs explored the social and structural context of FSWs living with HIV, including stigma and 
discrimination against PLHIV, and examined the PHDP needs and existent services related to HIV 
diagnosis, health services, HIV care and treatment, and prevention of HIV transmission. 
Characteristics of the qualitative study sample 
FSWs were purposively selected to participate in IDIs and FGDs. They were recruited through 
existent relationships, HIV clinics, NGOs, and networks of PLHIV in order to include participants 
who had diverse perspectives and experiences related to PHDP. All participants were FSWs who 
met the following criteria: 
 Participants exchanged sex for money in the last month;  
 Participants were HIV-infected; 
 Participants were able to provide verbal informed consent;  






IDIs and FGDs first explored participants’ general life experiences in order to facilitate rapport. 
The key domains that were then discussed included participants’ experiences of and with:  
 Stigma and discrimination 
 HIV diagnosis 
 Health services 
 HIV care and treatment 
 HIV prevention, including the use of condoms and sexual negotiation 
Interviews also explored participants’ suggestions for how each of the above could be improved 
and tailored to meet the needs of FSWs.  
Qualitative data collection 
In-depth, qualitative interviews were conducted with 20 FSWs living with HIV on two occasions 
at a mutually agreed upon time. All research took place in Santo Domingo, DR within the HVRU 
of IDCP. HVRU is comprised of a dynamic, expert team that has extensive experience with 
implementation of HIV research with FSWs. The unit was established in 2003 with support from 
the HIV Vaccine Trial Network (HVTN) of the US National Institutes of Health and represents a 
partnership amongst IDCP, a Dominican non-governmental organization and the National 
HIV/AIDS/STI Control Program of the Ministry of Health (DIGECITSS).114  
Prior to the start of each interview, field workers explained the study to participants and 
obtained verbal informed consent for participation and to audio record the conversation. The 
interviews were conducted in Spanish by trained, female field workers using semi-structured 
interview guides. Semi-structured interviews facilitate discussion of the same key domains 
across interviews, while still allowing for exploration of participants’ experiences and for 




Three FGDs were conducted with 24 FSWs living with HIV who were different from those 
included in the one-on-one interviews. FGDs were conducted in the IDCP office building and 
were facilitated by experienced study staff. These FGDs were conducted in order to explore the 
same topics from a community perspective and to specifically discuss possible intervention 
ideas. FGDs are particularly well-suited to exploration of the suitability of interventions, such as 
Abriendo Puertas, for the intended audience.115 
Qualitative data analysis 
Data analysis was conducted by the student investigator through immersion and intimate 
knowledge of data. All transcripts were reviewed twice prior to analysis by the student 
investigator and clarification was sought from the field workers who conducted the interviews, 
as necessary. All interview transcripts were imported into Atlast.ti 6.2.16.116 Data were analyzed 
in Spanish to maintain fidelity to the original meaning of participants’ statements. The student 
investigator employed thematic and narrative analysis in order to identify salient influences and 
to holistically explore participant experiences along the HIV care continuum.  
IDIs were analyzed using narrative analysis through detailed descriptions of each participant’s 
experience from HIV testing to the time of the interview. These narratives provided a more 
complete understanding of participants’ experiences over time and of how participants made 
sense of their own experiences.115 The narratives of the twenty participants were compared 
against one another to identify commonalities and distinct experiences. During this process, the 
student investigator identified recurrent influences on engagement at the individual, 
interpersonal, environmental and structural levels. Based on this emergent framework, a table 
was developed that described the salient experiences at each level of the twenty participants. 
While this table facilitated a clearer understanding of the levels, it was noted that the 




participant narratives were reorganized into a chronological table that described participants’ 
experiences at HIV diagnosis, in pre-ART care and in ART care. Four participants’ narratives that 
were representative of the breadth of participant experiences were then selected for inclusion 
in Table 4.1. The other 16 narratives are included in Appendix A. 
FGDs were thematically coded to identify salient themes and experiences. Preliminary coding 
used an open coding approach. These codes were organized into an emergent framework 
grounded in the IDI and FGD data that focused on individual, interpersonal, environmental and 
structural barriers and enablers along the HIV care continuum. Efforts were made to challenge 
emergent theory and to identify disconfirming evidence as all remaining transcripts were coded.  
Throughout data analysis, the student investigator developed operational and theoretical 
memos on the analysis process in order to enhance transparency and facilitate consideration of 
the relationships between codes. The student investigator also discussed study findings with 
subject experts and FSWs to enhance trustworthiness of interpretation. It was not possible, 
given that the data were already collected, to use a fully grounded approach to the data 
analysis, but key elements of grounded theory were employed. Specifically, there was a cyclical 
process between coding and theory generation and constant comparison between the interview 
transcripts.115,117 
Quality assurance and quality control 
Participants were interviewed on two occasions to enhance rapport and to explore key domains 
in greater depth. Each field worker had extensive experience in qualitative research with 
vulnerable populations and was trained on the purpose of the research study and on how to 
probe appropriately. Field workers completed structured reports on the interview context and 
experiences after each interview and all interviews were digitally recorded to ensure that data 




their original Spanish in order to better understand the context and nuances of how the data 
were constructed. She was reflexive throughout data analysis on the influence of her own 
background as a public health student from the US on her understanding of participant 
experiences. The student investigator was in regular contact with the team in the DR in order to 
discuss emergent themes and findings in order to enhance the trustworthiness of her 
interpretation. 
Analysis of the data from the qualitative phase of the dissertation informed the refinement of 
the student investigator’s understanding of the dissertation topic and assisted in the 
identification of key variables for inclusion in the second, quantitative phase. In the second, 
quantitative phase, baseline surveys were conducted with the 268 FSWs living with HIV who 






In response to the high unmet PHDP needs of FSWs living with HIV, a team of researchers from 
the Project SEARCH: Research to Prevention project at the Johns Hopkins Bloomberg School of 
Public Health (JHSPH) collaborated with research and community partners in Santo Domingo, DR 
to develop the Abriendo Puertas (opening doors) intervention. These partners included a local 
research unit that has been working with FSWs in Santo Domingo for over fifteen years (HVRU), 
a FSW activist organization and local health clinics. Abriendo Puertas (AP) was a multi-level 
intervention with FSWs living with HIV in Santo Domingo that sought to facilitate overall well-
being, including utilization of HIV services and consistent condom use with all sexual partners. 
The intervention was designed based on years of experience working with the study population, 
formative research findings with the study population and consultation with local 
implementation partners. This formative research, analyzed by the student investigator, 
included key informant interviews with 31 clinicians, NGO staff and other experts working with 
FSWs, MSM, TW and/or PLHIV. It also included IDIs with 20 FSWs, 16 MSM and five TW living 
with HIV and six focus group discussions with FSW, MSM and TW living with HIV. The IDIs and 
FGDs with FSWs from the formative research were the data source for the qualitative phase of 
this dissertation. 
There were five components of the AP intervention that targeted multiple levels including the 
individual, interpersonal, institutional, and community levels: 
 Six individual counseling sessions with trained psychologists, using a set curriculum; 
 Peer navigation with FSW peer navigators who facilitated HIV care and prevention 
service navigation and provided additional support and education, as required; 
 Monthly support group meetings and other community mobilization activities; 
 Trainings of local health clinic staff on how to effectively provide services for FSWs and 




 Male partner engagement and offering of voluntary HIV counseling and testing services. 
The AP intervention was piloted with 268 FSWs living with HIV in Santo Domingo, DR from 
December 2012 to December 2013. The effectiveness and appropriateness of the model was 
determined through quantitative and qualitative research methods with the AP cohort. The 





Quantitative Phase Research Methods 
The two quantitative aims, to describe the HIV care continuum in FSWs living with HIV and 
examine the factors associated with experience of treatment interruption in FSWs living with HIV  
and to determine the factors associated with retention in HIV care in FSWs living with HIV, were 
addressed through cross-sectional surveys with the 268 FSWs living with HIV who were 
participants in the AP cohort. The baseline surveys, conducted from November 2012 to February 
2013, included questions on participants’ sociodemographic attributes, sexual practices, HIV 
diagnosis, HIV disclosure, experiences with STIs, perceptions of health services, existent 
psychosocial support, and engagement with community mobilization activities. The survey also 
included questions on engagement in HIV care and experience with ART. Additionally, samples 
were collected from each participant to test for HIV viral load and the presence of STIs.  
Characteristics of the quantitative study sample 
The entire AP cohort (n=268) was included in the quantitative study population. They 
underwent an eligibility screener prior to the baseline survey and start of the intervention to 
ensure that they met the following criteria: 
 Participants must have exchanged sex for money in the last month;  
 Participants must have been HIV-infected, as confirmed through baseline HIV screening 
using a Retrocheck rapid HIV test; 
 Participants must have been willing to provide informed consent;  
 Participants must have been at least 18 years old. 
The cohort members were recruited using a non-random sampling approach through three 
mechanisms: referral from peer navigators; existent relationships with IDCP; and referral from 





Aims two and three used the same independent variables from the baseline survey. These 
variables included sociodemographic variables and the key variables that were identified as 
salient within the qualitative analysis. Scales are described in greater detail in the section, 
refinement of scales.  
Independent variables 
 Predisposing factors 
o Age 
o Marital status 
o Number of children 
o Household composition 
 Enabling Factors 
o Disclosure of HIV status  
o Existent psychosocial support scale118 
o Perceived HIV provider quality scale119 
o Perceived quality of HIV services 
o Experience of stigma and/or discrimination in health services120 
o Experience with pre-, post-, and ART-counseling  
o Cost and travel time to attend HIV services 
o Monthly income 
o Medical insurance coverage 
 Health need 
o Perceived health status 
o Evaluated health status 
 Year of HIV diagnosis 
 Year of ART initiation 
 History of opportunistic infections 
 Vulnerability 
o Substance use 
o Education 
o Mobility 
o Duration as SW 
o Age at start of SW 
o Location of SW 
o Self-stigma related to SW status scale
108,109
 






Aim two described the baseline HIV care continuum among AP cohort members. The definitions 
of each of the steps of the HIV care continuum, as self-reported by study participants or 
determined through laboratory testing, are described in Table 5.1. The key dependent variable 
of interest for aim two was history of treatment interruption among women ever initiated onto 
ART. A participant was defined as having a history of treatment interruption if she answered 
“yes” to the question, “Have you ever stopped or suspended taking ART (the medication for 
HIV)?” 
The dependent variable of interest for aim three was retention in HIV care. Retention was 
defined in two separate ways for the study. The first definition, “Attended”, categorized 
participants as retained if they reported attendance at an HIV clinic in the past six months, as 
determined by the question, “Have you received medical attention related to HIV in the last 6 
months?” The six month measure was selected for this study because it could be easily collected 
in operations research and was not affected by different clinical scheduling practices across 
clinics.30 The second definition, “Perfect Attendance” categorized participants as retained if they 
reported receipt of HIV care in the past six months and also reported that they did not miss any 
HIV service appointments in the past six months, as determined through the question, “In the 
past 6 months, have you missed for whatever reason an appointment at [your HIV clinic]?” 
Missed visits were treated as a dichotomous measure, in keeping with previous research.121 This 
second measure included both a kept and a missed visit measure, as has been suggested as best 
practice.36 Participants who attended HIV services in the past six months, but also missed an 






Quantitative data collection 
Each study participant completed baseline, paper quantitative surveys between November 2012 
and February 2013. The interviews were conducted in Spanish by trained, female field workers 
in a private room in the IDCP. Field workers conducted mock interviews during training in 
August 2012 to ensure that they had clear and consistent understanding of the questions and to 
ensure appropriate skip patterns and flow of questions. The student investigator co-facilitated 
this training of field workers. The survey was then piloted with FSWs living with HIV in Santo 
Domingo. Following the initial piloting, the field workers and FSWs living with HIV provided the 
local study team and the student investigator with feedback on the questions and the overall 
survey. The survey was then amended and re-piloted prior to use with the study population. The 
student investigator was in the DR for the piloting and refinement of the baseline study 
instrument.  
Quantitative data management 
The student investigator returned to the DR to review the first completed surveys and to help 
refine data management procedures in November 2012. It was determined that all hard copies 
of quantitative surveys would be signed over from the field worker to the study data manager at 
the end of each day. All hard copies of the surveys were kept in a locked cabinet within a locked 
office at IDCP. These surveys were then dual-entered into an electronic database by trained field 
workers. Electronic copies of the survey data were stored on a password-protected computer at 
the local study office and backed up on a secure external hard-drive. These files did not contain 
identifying information.  
Quality assurance and quality control 
Diverse quality assurance (QA) and quality control (QC) mechanisms for the study included 




a comfortable, confidential environment, and active QA/QC procedures for the data collection 
and management. Each field worker had extensive experience in quantitative data collection 
with vulnerable populations and underwent further training in quantitative methods and ethical 
study practices prior to the start of the study to ensure quality of survey implementation. All 
surveys were reviewed for QC and any issues were promptly discussed and addressed with the 
field workers.  
Mechanisms were also in place to minimize bias throughout the study. Interviews were 
conducted in private rooms and participants were reminded that there was no correct answer 
to the questions in order to reduce social desirability bias. Survey questions included clear and 
appropriate time references to minimize recall bias. Additionally, the survey instruments were 
piloted to assess face validity and validated scales were used, when possible. The local team also 
had extensive experience working with FSWs and had a positive reputation within the broader 





Quantitative data analysis 
All statistical analysis was conducted using Stata.122 Prior to analysis, data were cleaned using 
frequency distributions, histograms and other descriptive statistics. During exploratory data 
analysis (EDA), the distributions of all variables of interest were explored through histograms, 
scatterplots and descriptive statistics. There were limited missing data within participant 
responses. These missing data were explored and there were no significant differences in 
individuals with or without responses for any of the variables of interest in this analysis.  
Refinement of scales 
The scales used in this study were developed from responses to questions with Likert scales 
ranging from one (strongly disagree) to four (strongly agree). Individuals who did not respond to 
a particular question had a neutral response (2.5) imputed for that specific question to ensure 
that this missed response did not bias their overall score.  
The first step in the development of each scale was to conduct principal components analysis 
(PCA) to determine the appropriate number of factors for inclusion. The number of factors was 
determined by the location of the elbow in the scree plot and comparison of eigenvalues. PCA 
for each scale indicated strong unidemsionality and the fit of each scale was stronger for one 
factor than for two. Factor loadings were determined using maximum likelihood estimation 
models. The communality of the factors were then calculated to ensure that the resultant 
factors explained a sufficient fraction of the variability in the questions (  ² >0.5). Items were 
dropped if they have uniqueness greater than 0.5 and / or the highest factor loading was less 
than 0.4. A composite score for each scale was then created by summing each participant’s 




HIV-related self-stigma was determined through eight questions that assessed participants’ level 
of agreement with statements, including “Having HIV makes you feel like a bad person” and 
“You feel guilty because you have HIV”, as adapted from validated, reliable HIV stigma 
scales.123,124 PCA suggested strong unidimensionality and the scale had high internal reliability 
(Cronbach’s alpha=0.87). Scores ranged from 8 to 32 with a median score of 18. Participants 
who reported more self-stigmatizing attitudes related to HIV-status had higher scores.  
SW-related self-stigma was determined through the same eight questions used in the HIV 
stigma scale, but with “SW” replacing “HIV”. The questions assessed participants’ level of 
agreement with a series of statements, including “You feel embarrassed to be a SW” and “You 
feel that you are not worth anything because you are a SW”. These questions were adapted 
from the aforementioned, validated HIV-related self stigma scales.123,124 The final eight question 
scale had one underlying factor and high reliability (Cronbach’s alpha=0.88). Scores ranged from 
8 to 32 with a median score of 18. Participants with more self-stigmatizing attitudes related to 
SW had higher scores.  
Participants’ perception of HIV service providers was determined through ten questions that 
assessed participants’ level of agreement with statements, including “Your doctor is well trained 
to take care of medical problems like yours”, and “You feel respected by your doctor”. These 
questions were adapted from the validated Patients Reactions Assessment scale.119 Eight 
participants did not respond to these questions and were excluded from this part of the 
analysis. The scale was refined through iterated principal factor analysis and two questions were 
ultimately dropped from the scale to enhance its internal consistency. Scores ranged from 8 to 
32 with a median of 26. The final, eight question scale had very high reliability with a Cronbach’s 





Participants were categorized as having experienced discrimination in the clinic related to their 
HIV-status if they indicated that they had ever received poor services, been denied medical 
attention or heard health personnel gossiping about them because they are living with HIV, as 
adapted from Baral et al.120 They were categorized as having experienced discrimination in the 
clinic related to their SW-status if they indicated that they had ever received poor services, been 
denied medical attention or heard health personnel gossiping about them because they 
exchange sex for money. 
Regression analysis 
The baseline characteristics of the study participants were described through bivariate analysis, 
comparing those who did and did not report ART interruption among those ever on ART (aim 
two) and comparing those who were and were not categorized as retained in HIV care by each 
retention definition (aim three). Categorical variables were compared using Pearson’s Chi-
square tests and continuous variables were compared using two-sided t-tests or ANOVA tests, 
as appropriate. Following these bivariate analyses, simple logistic regression (SLR) analyses were 
conducted with each key independent variable from the EDA and the binary outcome of ART 
interruption (aim two) and the binary outcome of retention in HIV care (aim three). Wald p-
values were used to test for significance in categorical variables. Multiple logistic regression 
(MLR) analyses were then conducted to assess the association of variables that were significant 
in SLR and the dependent variable of interest in each aim. Models were constructed using a 
forward stepwise approach. Starting with a null model, variables with p<0.10 in SLR were added 
to the model until the best model was constructed, as determined by comparison of log 
likelihood ratios and Akaike Information Criterion score (AIC). Additional variables were added 
to the model until the lowest AIC was obtained, while maintaining parsimony of model. Residual 




for the logistic regression was determined by running the regression as a linear regression in 
order to determine the variance inflation factors. Forward and backward step-wise procedures 
with a p-value of 0.05 were then conducted to ensure that no variables were dropped due to 
collinearity. The overall degree of fit for the final model was determined using the Hosmer-




Protection of Human Subjects 
The qualitative and quantitative phases of this study were approved by the JHSPH institutional 
review board and the IDCP review board. Rose Zulliger was included as a student investigator on 
both of the projects. 
Informed consent  
All participants had the study described to them in detail by a trained field worker prior to study 
enrollment. Participants were informed that their participation was entirely voluntary and that 
they could discontinue participation in the study at any time. Following this process, participants 
provided verbal informed consent using a consent form written in Spanish that was approved by 
the JHSPH and local ethics review boards.  
Subject confidentiality 
Participants completed all study interviews in a private location and data were stored without 
identifying information. The only document linking participants’ study codes to their name, 
address and phone number was maintained on a secure password protected computer at the 
HVRU site. After each participant completed her 10 month follow-up survey, her personal 
information was deleted from the secure computer, unless she agreed to be contacted for 
involvement in future studies. Additionally, no names or contextual information that could 
identify an individual were included in any publication or report generated from this study. 
Potential risks and risk management procedures 
FSWs living with HIV are a group with heightened vulnerability to stigma, discrimination and 
exploitation.4 Participation in this study may have exposed participants to heightened social risk 
if others discovered that they were involved in SW or living with HIV through their study 




unpleasant to discuss. The research team held extensive meetings with local partners, along 
with the JHSPH and local Santo Domingo ethical review boards to ensure that the intervention 
and study were in accordance with ethical best practices. Additionally, all participants were 
linked to a licensed counselor through the AP intervention who could provide them with 
additional support, as required. 
Cohort participants each spent approximately 1.5-2 hours completing the baseline study 
surveys. Formative, qualitative interviews and FGDs lasted approximately 1.5-2 hours. 
 In response to these potential risks, all participants were reminded that their participation was 
completely voluntary. They were also informed that they did not need to answer any of the 
questions that made them uncomfortable and that they could discontinue involvement at any 
time. Additionally, field workers were trained to recognize mental distress and could make 
referrals to the study counselors, as appropriate.  
Potential Benefits 
The main benefit of involvement in this study for participants was the opportunity to participate 
in the AP intervention components. This intervention may have increased participants’ access to 
medical care, treatment and prevention and improved their social and emotional support and 
well-being. Participants were also provided with their STI and HIV viral load test results and 
were given the option of sharing these results with their HIV clinic. Participants were given the 
opportunity to invite their sexual partners to the study office for voluntary HIV counseling and 
testing without disclosure of their own HIV status. Additionally, there were substantial societal 
benefits from the study through improved understanding of how to operationalize PHDP in 





Participants were compensated for their time through payment of 400 Dominican pesos 
(approximately US$10) for completion of each study visit. FSWs who completed both the 
baseline and ten month study visits received an additional 400 pesos at the completion of the 
study. They also received 400 pesos for each counseling session that they attended (maximum 
of six) to cover their transportation costs.  
Most FSWs could receive a total remuneration of 3600 pesos ($90) if they completed both 
surveys, received the study completion compensation, and attend all sixed counseling sessions 





Chapter 4. Experiences of female sex workers living with 





Female sex workers (FSWs) are disproportionately affected by HIV and face additional barriers 
throughout the HIV care continuum. This study explored their experiences with HIV care in the 
Dominican Republic through 40 in-depth interviews and three focus group discussions with 44 
FSWs living with HIV. Data were analyzed in Spanish using narrative and thematic analysis. FSWs 
living with HIV experienced considerable movement in and out of HIV care over time. FSWs 
described individual, interpersonal, environmental and structural factors that either facilitated 
(re)engagement in HIV care or led to disengagement throughout the HIV care continuum. Key 
individual-level factors were physical and mental health as post-diagnosis depression often led 
to disengagement until declines in physical health. At the interpersonal level, disclosure of HIV 
or FSW status and receipt of emotional or economical support were frequently instrumental in 
facilitating engagement with HIV care. Yet negative reactions to or lack of disclosure 
complicated access to support and to HIV clinics. At the environmental level, participants were 
generally satisfied with HIV clinic staff, but they described considerable challenges with the 
health system organization, frequent delays and costs of care. Participants also described 
pervasive stigma and discrimination related to both their HIV status and their sex work, 
including some experiences of discrimination within clinics. Finally, lack of economic resources 
complicated adherence to clinical appointments and to antiretroviral therapy. In addition to 
challenges faced by the general population living with HIV, FSWs confronted economic 
instability and the compounded stigma of being both HIV-infected and a FSW. Engagement in 
HIV care among FSWs was continually negotiated within a broader context of structural 
constraints and social conditions. Factors at multiple levels influenced engagement and 
experiences at one step affected subsequent engagement. These findings underscore the need 
for the provision of support tailored to the unique needs of FSWs throughout the HIV care 
continuum in order to maximize individual and public health. 
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Despite the individual and public health benefits of engagement in HIV care,36 people living with 
HIV (PLHIV) temporarily or permanently disengage from care throughout the dynamic pathway 
from HIV infection to viral suppression on antiretroviral therapy (ART),28,30 and patients often 
cycle in an out of care.31-33,125 There has been increasing interest in engagement in the HIV care 
continuum, but most studies have utilized cross-sectional and quantitative methods, limiting our 
understanding of the dynamic and lived experiences of individuals throughout the 
continuum.24,36 Additionally, previous research has noted the importance of multiple levels on 
engagement in HIV care,7 but the interplay of these levels has not been adequately described.36 
PLHIV frequently confront barriers along the care continuum and these can be particularly 
challenging for groups such as female sex workers (FSWs), a population that is 
disproportionately affected by HIV.1 There is substantial evidence on the effectiveness of HIV 
prevention strategies with FSWs, but there has been little research on the experiences of FSWs 
living with HIV.2,3 The limited evidence suggests that FSWs experience considerable barriers to 
HIV care linkage and retention4-6 at multiple levels, including stigma and discrimination.3,7,8,94,95 
To address these research gaps, this study explored the experiences of FSWs living with HIV 






In-depth interviews (IDIs) and focus group discussions (FGDs) were conducted with FSWs living 
with HIV in Santo Domingo, Dominican Republic (DR) from August 2011 to February 2012. The 
DR has a concentrated HIV epidemic with an elevated HIV prevalence of 3.3%-8.4% in FSWs126 
and a national prevalence of approximately 0.7%.80 FSW participants were purposively selected 
and recruited through HIV clinics, NGOs, relationships with the study team and networks of 
PLHIV to include participants with diverse perspectives. All participants were over 18 years old, 
had exchanged sex for money in the month preceding interviews and had received an HIV-
positive diagnosis. Participants’ year of diagnosis ranged from 1996 to 2011. 
A total of 40 IDIs were conducted with 20 FSWs living with HIV by experienced, female field 
workers using semi-structured interview guides. These guides explored participants’ experiences 
with HIV diagnosis, health services, HIV care and treatment, and prevention of HIV transmission. 
Participants were interviewed on two occasions to facilitate interview depth and rapport. Three 
FGDs were conducted with an additional 24 FSWs living with HIV. These FGDs explored the same 
topics from a community perspective, along with possible intervention ideas. All participants 
provided verbal informed consent and the study received ethical approval from the Institutional 
Review Boards of the Instituto Dermatológica y Cirugía de Piel Dr. Huberto Bogaert Díaz and the 
Johns Hopkins Bloomberg School of Public Health. 
Data analysis was conducted through immersion and intimate knowledge of data. All transcripts 
were analyzed in Spanish using Atlast.ti 6.2.16.116 IDIs were analyzed using narrative analysis.127 
Narratives of participants’ descriptions of experiences from HIV testing to the time of the 
interview were developed. They specifically explored participants’ trajectories of care and 




narratives provided a more complete understanding of participants’ experiences over time.115 
Four participants’ narratives that were representative of the breadth of experiences were then 
selected for more detailed presentation. The remaining 16 narratives are included in Appendix 
A. 
FGDs were thematically coded to identify salient themes and experiences. Initial coding used an 
open coding approach. These codes were then organized into an emergent framework 
grounded in the data that focused on individual, interpersonal, environmental and structural 
barriers and enablers along the HIV care continuum. Efforts were made to challenge emergent 
theory and to identify disconfirming evidence as all remaining interview transcripts were 
coded.115,117 Study findings were discussed with subject experts and FSWs in order to enhance 





FSWs living with HIV in the DR described critical barriers and enablers throughout the HIV care 
continuum. Participants’ narratives provided a holistic overview of their lived experiences along 
the continuum. Table 4.1 includes summary narratives of the experiences of four FSWs living 
with HIV- referred to by the pseudonyms of Catalina, Carla, Lupe and Valentina- along this 
continuum. Participants frequently moved in and out of HIV care. They experienced distinct 
challenges at each step along the HIV care continuum, but there were persistent factors that 
emerged from the data at the individual, interpersonal, environmental and structural levels that 
either facilitated (re)engagement or led to disengagement in HIV care throughout the 





Figure 4.1 Key influences on engagement, re-engagement, and disengagement in HIV care 
experienced by female sex workers at the individual, interpersonal, environmental, and 
structural levels throughout the continuum of HIV care 
 
At the individual level, participants described the important role of their health on engagement. 
Participants like Carla often delayed HIV testing or HIV clinic attendance when they felt 
physically well, but declining health motivated (re)engagement with HIV care. Mental health 
issues such as depression and suicidal ideation, as described by all four participants in Table 4.1, 
often impeded sustained engagement. At the interpersonal level, disclosure of HIV or sex 
worker (SW) status and receipt of emotional or economical support were frequently 
instrumental in facilitating engagement with HIV care. Yet negative reactions to or lack of 




involuntary disclosure of Catalina’s HIV status left her depressed and planning to disengage from 
care. At the environmental level, health system characteristics were important as negative 
experiences in health services were frequently followed by disengagement in care. Thus, 
previous experiences with health services along the continuum influenced subsequent 
engagement. Finally, structural factors such as stigma and discrimination related to HIV and SW 
status and access to economic resources were important. The salience of each level varied for 
every woman, but participants consistently described the importance of these multiple levels in 
their engagement in HIV care. Using this emergent, organizing framework, we describe 





Table 4.1 Narratives of four female sex workers (FSWs) living with HIV along the HIV care continuum in Santo Domingo, Dominican Republic 
Pseudonym Catalina Carla Lupe Valentina 
HIV testing  
and 
diagnosis 
Catalina went to the hospital in 2004 
after experiencing stomach problems. 
The doctors ordered a number of 
laboratory tests, but Catalina did not 
know that they were doing an HIV test. 
Catalina learned of her HIV status when 
she overhead the clinicians tell her 
friend that Catalina tested HIV-positive. 
In response to this diagnosis, Catalina 
became very depressed and suicidal and 
her health deteriorated, “I became bad, 
depressed, there I started to get sick and 
I got sicker. Then I reached the AIDS 
stage.” Catalina quit her job cleaning 
houses and told many people that she 
was dying of AIDS. Catalina’s family is in 
Haiti, but her friend visited her after her 
diagnosis and brought her food. 
Catalina met a patient at the hospital 
who saw her when she was upset. The 
patient informally connected Catalina to 
a peer navigator who visited her at her 
house.  
Carla and her husband were 
instructed to test for HIV in 2001 
when their child was sick. The 
clinicians initially did not want to 
provide them with their test results, 
but they later gave Carla her diagnosis 
and told her that “there were places 
where they give medications to help 
me and that one can live with the 
virus by taking care of herself.” Upon 
receiving her diagnosis, Carla was 
distraught and felt as though “the 
world was falling on me” and was 
shocked since she was a housewife. 
Her child later died and “when my 
daughter died I blamed myself for 
this. I blamed myself that this 
happened to my child… I tried twice to 
throw myself from a bridge… I 
suffered and I am still suffering.” After 
her HIV diagnosis, Carla began to 
work as a FSW because her partner 
blamed her for their HIV and she felt 
she was lost since she had HIV. 
Lupe was diagnosed with HIV in 
2003 when she was required to 
test by work. She was very 
depressed and shocked, “I felt that 
it was a dream, that it was a lie… I 
thought that they were wrong 
about the test and I had an attack, 
I screamed a lot… I tried to drink 
bleach because I thought that 
bleach would poison me.” The 
doctor referred Lupe to an HIV 
clinic, but she delayed attending. 
In response to Lupe’s diagnosis, 
Lupe’s mother reached out to an 
educator from an organization 
that works with FSWs. Eventually 
the educator brought Lupe to a 
psychologist. 
Valentina tested HIV-positive 
in 1996 after her child was 
diagnosed with HIV. She was 
required to bring someone 
with her to receive her test 
result because “in that time 
they did not have treatment 
for people because now and 
that time before are very 
different because in that time 
they did not want to tell me 
anything. You have to come 
with someone.” 
When diagnosed, Valentina 
thought of the discrimination 
against PLHIV and felt 
depressed, “I saw the way 
they treated someone with 
the same condition as me. I 
said, ‘look how they treat him. 
‘Look, he has AIDS. Look at 




Catalina did not receive a referral to HIV 
care at diagnosis, but she was brought 
to an HIV clinic by the peer navigator. 
Her relationship with peers was integral 
in her coming to terms with her 
diagnosis, “It was difficult when I 
learned that I had HIV. I wanted to kill 
[myself], I did not want to live. Later I 
met my [peer navigator] and I started to 
go out, to go to workshops and those 
types of things. I started to see my 
Carla linked to an HIV clinic, but did 
not like it there because “I saw people 
from my community and I left. And 
this lasted for four years.” She only 
returned to an HIV clinic after she was 
hospitalized with drug-resistant 
tuberculosis (TB).  
Carla is not on ART because her CD4 
count is high, but she is still on TB 
treatment. Carla has received good 
care from both her HIV clinic and her 
Lupe’s mother took her to an HIV 
clinic, but Lupe became hysterical 
because of how sick people 
looked, “When they made me the 
appointment I did not want to go 
when I saw this thin and dry 
person.” Lupe started to lose 
weight and did not know how to 
take care of herself. Her health 
deteriorated, but it later 
improved. She learned what food 
While in pre-ART care, 
Valentina became involved in 
a support group that “made 
me understand that people 
living with HIV have the same 
rights as other people.”  
Valentina’s partner was 
supportive of her and took 
care of her when she was very 
ill. This support was incredibly 




colleagues who live with HIV and I said if 
they are living why[can’t I]?”  
Catalina is happy with the care that she 
receives at the HIV clinic and has never 
seen anyone treated poorly there. 
“They are all really good. They give me a 
lot of support, a lot of love and 
sometimes they also fight with me… 
Because sometimes I arrive late or I 
forget the time to take the medicine.”  
deceased daughter’s doctor 
sometimes gives her money. 
Carla experiences considerable 
stigma, “I am suffering and I suffer 
because I am afraid that people know 
I have [HIV].” She has not disclosed 
her HIV status to her mother for fear 
of giving her a heart attack or to her 
siblings because, “I don’t think that I 
should give this pain…. Sometimes I 
feel the need to tell them, to share my 
troubles, but I don’t feel alone. I go 
into the bathroom and I talk with 
God.” 
helped her and is in touch with her 
body.  
Many people in Lupe’s community 
gossip about her HIV status and 
they told Lupe’s children that she 
has AIDS. Lupe was fired from a 
job for having HIV. She has also 
had her HIV status disclosed by 
other FSWs. 
Lupe later went to a private HIV 
clinic where she received very 
good care, “the doctors are good 
and they are always giving one 
attention. You know that it is 
private and then sometimes one 
goes without money and they 
attend to you.” 
told me that I am here with 
you until death… and [his 
support] is a marvelous thing. 
They are still friends, but she 
told him that they could not 
be together because she did 
not want to infect him.  
Valentina’s daughter knows 
that she has HIV, but not 
about her sex work because 
“she has accepted one thing, I 
know that she has accepted 
everything, but I cannot 
manage this [disclosure of sex 
work] yet with her.” Her 
daughter always cheers 
Valentina up when she is sad. 
ART care Catalina was initiated onto ART in 2005 
and she now has an undetectable viral 
load. She does not take her ART at the 
same time every day because she often 
lacks money for food and transportation. 
Catalina stated, “I would like to quit [sex 
work], but sometimes I say, no, I have to 
do it because I have to eat and collect my 
treatment. For example, I have an 
appointment to collect medication and I 
do not have money to go collect it. I have 
to go out [as a FSW], but it is how I 
survive.”  
Catalina’s has a network of friends who 
have helped her and provided her with 
economic support. “Sometimes I do not 
have money to buy [food], but I always 
have a friend who tells me, ‘take this’ or’ I 
store my food here.’” She has also 
borrowed ART other PLHIV who take the 
When asked about starting ART, Carla 
said that she would need a psychologist 
to cope because it would be too 
difficult for her to take ART in addition 
to her TB treatment. Carla sometimes 
feels depressed because she has both 
HIV and TB, but she copes with HIV by 
not thinking about it. 
Lupe no longer attends HIV services. 
When asked about ART, Lupe 
stated, “I dread the medications 
because I don’t know; I have seen 
how people are when they start, the 
nausea it gives, the side effects.” 
Lupe feels that she has “learned to 
control my body.” She is, however, 
active in associations of PLHIV and 
proud of the work that she does. 
The members of her support group 
take care of one-another and bring 
each other food, “I feel happy with 
all of my companions when we are 
together it is like a tremendous 
happiness.” 
Valentina was initiated onto 
ART in 2007. The treatment 
initially made her nauseous and 
depressed, but the side-effects 
subsided. She did, however 
have a one month break in ART 
when she was sad after her 
daughter went to stay with 
Valentina’s mother. Valentina 
later re-initiated ART. She has a 
very good relationship with her 
doctor and with the clinic 
counselors who “give love and 
give kindness”.  
Valentina is active in her 
community providing HIV-
related education and support, 
“I feel very proud of my work 
that I am doing. I am helping 




same drug regimen. 
Catalina was happily engaged in care at 
the first study visit, but someone 
disclosed Catalina’s HIV status at her sex 
work establishment in between the two 
interviews and she was attacked by the 
other FSWs. Following this experience, 
Catalina expressed desire “to leave 
treatment and stay in the house to wait 
for death.” Her peer navigator has, 
however, arranged for her to speak to a 
psychologist. 
problem as me. Because no one 
has to be like me.”  
 
 
HIV testing and diagnosis 
Participants described a range of motivations for and experiences with HIV testing. Key 
individual and interpersonal motivators of HIV testing were feeling unwell or having sick or HIV-
infected partners and children. Yet other factors were also influential as some women like Lupe 
were instructed to test when pregnant or required to do so for work. Once tested, many 
participants experienced considerable delays in diagnosis. They were often told by health care 
providers that their first HIV test was damaged and that they had to be re-tested. Participants 
like Catalina also reported that health care providers refused to give them their results directly 
and instead gave their HIV test results first to family members or friends. Delays were, however, 
less common among more recently diagnosed participants and one participant received her HIV 
test results within ten minutes. Participants described generally empathetic care from health 
service providers, and particularly appreciated guidance from HIV-positive counselors because 
they motivated participants through their own experiences.  
Despite post-test counseling, almost all participants mentioned feelings of depression following 
diagnosis. They frequently described the time following diagnosis as “chaotic” and many were 
suicidal. One woman stated that at diagnosis, “For me in that instant it was a depression, a 
depression like something that you cannot describe. Everything hurts and you cannot really say 
what hurts.” This sadness was compounded for women who were pregnant when diagnosed. “It 
was very difficult for me,” explained one woman, “because when they told me that I was 
positive I was pregnant and this was double the pain for me.” Others were angry, particularly 
when they felt that they knew who had infected them. 
Participants often came to terms with their diagnosis through interpersonal relationships with 
family, friends, and peer navigators. One participant explained, “I wanted to die, but my sister 
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helped me and told me that no, that I am going to get up and everything was going to continue 
normally.” Participants also drew inspiration from friends and counselors who were known to be 
living with HIV. Disclosure was, however, very difficult for many participants as they had to 
balance disclosure of both their HIV and FSW statuses. Many participants, like Valentina, only 
shared their HIV status with their families, but not their work. Others, like Carla, did not want to 
upset their families and kept both statuses a secret. Disclosure to sexual partners was 
particularly difficult. One participant explained that she was blamed for the HIV infection by her 
partner’s family, “since I am in the street [a FSW], they thought that it was me, being in the 
street, that it was me who infected him.”  
Health care providers also facilitated engagement in HIV care. Participants frequently 
mentioned that providers gave them their personal phone numbers, food, money and vitamins. 
One participant explained how the psychologist who diagnosed her helped: 
When they told me what I had I ran away like a madwoman. 
They grabbed me and I started to yell, to shout out and the 
psychologist began to hug me and console me... I found myself 
in the hands of a friend, that she was my friend, my confidante, 
my everything.  
Some participants did, however, describe upsetting experiences with HIV-related discrimination 
within general health clinics. One explained, “There are people in the hospitals that treat you at 
a bit of a distance once they learn you are [HIV-positive]” and some clinic staff involuntarily 
disclosed participants HIV status. These negative experiences in health services were followed 
by disengagement in care for some participants. 
Pre-ART care 
Participants generally received information about HIV clinics at the time of their diagnosis, but 
most delayed attending because of individual factors such as feeling healthy or interpersonal 
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reasons like lack of HIV disclosure. Participants like Catalina described waiting for advanced 
illness prior to engaging in HIV care. One participant had never attended an HIV clinic because, 
“I do not have any symptom that alerts me that I have to go and get checked. If one day I fall ill, 
then I will go and get checked.” Lack of disclosure also complicated engagement as some had 
“hidden HIV” and, therefore, could not be seen entering clinics that frequently had HIV-related 
signage.  
Once their HIV status was known or assumed, many participants described pervasive stigma and 
discrimination within their communities. Some participants delayed engagement in HIV care 
because they feared HIV-related discrimination in addition to the discrimination that they 
already faced as FSWs.  
I did not take care of myself because I was worried that people 
would know that I live with the illness. Because nowadays 
people discriminate against one for being a sex worker and also 
if one is infected with HIV. 
Some communities learned of participants’ HIV status when it was involuntarily disclosed. 
Community members also inferred that some participants had HIV because they had lost 
weight. This discrimination affected participants’ mental and social health and led some to seek 
care from clinics that were further from their communities.  
Despite these barriers to HIV clinic attendance, many participants linked to services through 
informal networks and peers. Peer navigators often reached out to participants in a discreet way 
and were instrumental in helping bring participants to HIV care. One participant explained, 
When [the peer navigators] found me they found me very 
sick... In that moment they gave me a lot of support, they lifted 
me up and I was in a place that I wanted to die, but with help, 
with the experiences and the learning that they gave me, I rose 
up and I learned. 
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FGD participants explained how the navigators take care of them, “like a nurse, like a friend, like 
a mother”. 
Once participants attended HIV services they were generally satisfied with HIV clinic staff, but 
they were frustrated by the health system organization and costs. Following their first HIV clinic 
appointment, patients in the DR are generally sent to the national laboratory for baseline 
assessments and then required to return to the laboratory to collect their results prior to 
accessing HIV clinical care, a system that participants felt was cumbersome: “You have your 
appointment, you go to do the labwork someplace else, the medication is not in the same place 
where you are… they give you a prescription to go to look for it in the other place, now here you 
have to wait, then there is a lot of congestion.” In addition to frustration, this system introduced 
additional transportation and laboratory testing costs. Some participants were able to borrow or 
obtain money from family or friends to defray the cost of pre-ART care, but many had 
competing demands for their money such as providing food for their children. This health 
system organization led some participants to disengage. “I attended [the clinic],” said one, “but I 
became disenchanted and I did not continue… doing so many turns, so many lines.” In addition 
to delays, participants were frustrated that they often received prescriptions to fill and pay for 
at the pharmacy instead of being given the medication or vitamins. One FGD participant 
explained, “The service in terms of the treatment from personnel I find excellent, but in terms of 
the availability of medicine for opportunistic infections, the services are rock bottom.”  
There were, however, important enablers of retention in pre-ART care. Many participants had at 
least some experience with HIV support groups, although most stopped attending over time. 
Support groups could be helpful because, as one participant described, “when we arrive, we 
arrive dispirited, depressed and by listening to the experiences of the other people, the coming 
together, we are animated. We leave from there revived.” Additionally, while a few participants 
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noted harsh treatment within some services, they generally described strong, supportive 
relationships with their care providers that motivated them to stay engaged in care. 
ART care 
Prior to ART initiation, participants experienced similar systemic delays in determination of 
treatment eligibility through CD4 enumeration. One disengaged participant did not initiate ART 
because she could not obtain her CD4 count results:  
The doctor sent me to the national laboratory to do a test and I 
went and I did it. Then when I went to look for the results I did 
not have money and I did not go. I did not return [to the clinic] 
again. I did not return because I have to do the CD4 analysis for 
the doctor to give me the medication. 
Many participants ultimately received their CD4 count results and were initiated onto ART, yet 
learning that they were treatment eligible was upsetting because ART was synonymous with 
advanced illness. One participant recalled, “When they talk to a person about treatment I 
thought that the person was dying.”  
Once initiated onto ART, participants described important factors influencing ART adherence 
such as lack of economic resources, dislike of pills, irregular schedules, experience of side 
effects, and access to support systems. Participants explained the importance of adherence and 
the value of treatment, but sometimes were not able to take all of their ART medications at the 
prescribed times. A common challenge was lack of transportation money to the clinic.  
There are times that, that one does not have money for the 
transportation or there are times that I only have 100 pesos. 
How could I leave my children hungry to come to the doctor? If 
there is an emergency with my pills, I make the sacrifice with 
pain in my soul, but if it is for a check-up I do not do it because 
it hurts me to be here, knowing that my children are hungry. 
Insufficient food also complicated adherence to ART. Others struggled with adherence due to 
ART side effects, particularly following ART initiation. Participants also sometimes reported 
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missing doses of ART because of their irregular schedules and alcohol consumption associated 
with sex work. They woke up and ate meals at different time of the day which made it difficult 
to take ART at regular intervals. 
Within ART care, participants described some systemic challenges, but generally good 
relationships with their care providers. Providers were, however, sometimes exasperated with 
participants like Catalina when they did not take their ART at the correct times. Systemic 
challenges included inconsistent drug supply. Participants reported receiving only two weeks’ 
doses instead of two months’ supply when their clinic ran low on ART. This was problematic as it 
meant that they had to spend more on transportation. 
Despite these challenges, many participants were able to develop techniques to facilitate ART 
adherence. These included keeping their phone with them so that they could check the time, 
always taking pills after breakfast and at the end of a soap opera, having family members 
remind them to take their doses and avoiding situations which would inhibit taking treatment.  
You can invite me to your house and if I cannot bring [my ART] I 
will not go because I learned the importance of those 
medications. I understand that they are very expensive and 
that… it is important that we take them on time. 
Participants also drew support from their social networks. A nurse at one participant’s clinic 
brought ART to her when she lacked transportation money. Multiple other participants, like 
Catalina, described borrowing pills from friends. Through individual, interpersonal and 
environmental support, many participants were able to reach viral suppression on ART. One 
participant said, “I feel good and healthy and I thank God for that and all of the doctors and the 
medicines that have helped me so that, thank God, my viral load is undetectable.”  
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Discussion  
FSWs living with HIV in this study described considerable movement in and out of HIV care over 
time, dependent on their individual, interpersonal, environmental and structural experiences 
throughout the HIV care continuum. Rather than experiencing a seamless transition from one 
step to the next, participants were continually confronted with barriers that complicated 
continued engagement and enablers that sustained them in care. The experiences at one step 
then affected engagement in subsequent steps, as has previously been described,24,34,128 and 
engagement in HIV care among FSWs was continually negotiated within a broader context of 
structural constraints and social conditions. 
The finding that each step in the HIV care continuum influenced subsequent steps has important 
implications for both research and practice. There is growing evidence on factors associated 
with distinct steps in the continuum such as linkage to or retention in HIV care.10,45,129,130 These 
studies provide important insight into key influences on engagement, but PLHIV must 
successfully complete each step in order to achieve the full benefits of engagement in HIV 
care.47 Additionally, the process of engagement in HIV care is often non-linear as PLHIV in this 
study and others frequently move in and out of care.31,32 This underscores the importance of 
qualitative exploration and longitudinal documentation of the lived realities of PLHIV 
throughout the steps in the continuum of HIV care24,36 to elucidate these dynamic pathways in 
and out of HIV care. This understanding will help policymakers and programmers to identify the 
key resources that can be leveraged or factors that must be addressed to support continued 
engagement or facilitate re-engagement in care. Additionally, recognition of key barriers to 
engagement such as lack of food or depression can help clinicians to identify in-care patients 
who may require additional support. 
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This study identified critical challenges and opportunities at each level for enhancing 
engagement of FSWs in HIV care. At the individual level, perceived and actual physical and 
mental health influenced engagement, as has been noted previously.3,24,47,48 Post-diagnosis 
depression, in particular, was frequently followed by protracted disengagement in HIV care, 
underscoring the importance of post-diagnosis follow-up and support. Participants in this study 
frequently waited to re-engage in HIV services until they felt unwell which may explain previous 
findings that PLHIV in the DR initiate ART at advanced stages of HIV.73,107 There is a clear need 
for additional counseling and public health messaging to increase awareness of the importance 
of HIV care when participants still feel healthy in order to expedite linkage to HIV care and 
facilitate retention in pre-ART care.  
At the interpersonal level, disclosure of HIV status and access to emotional and economic 
support were important. Participants frequently described individual depression and structural 
poverty, but some were able to surmount these challenges with the support from friends and 
family. Yet negative social experiences such as the disclosure of Catalina’s HIV status at her sex 
work establishment inhibited sustained engagement in HIV care, as was also noted among FSWs 
in India.48 More formalized support from HIV-positive peer navigators and support groups was 
also vital in facilitating and sustaining engagement in care amongst study participants, as has 
been previously described.33,36,95,131 Additionally, active case management has proven to be 
effective in improving linkage and retention in HIV care36,132 and warrants further examination 
with key populations such as FSWs.  
At the environmental level, FSWs’ engagement in care was influenced by the organization of the 
health system, the availability of medicines and the strength of provider relationships, a finding 
that is consistent with prior research.51,52,128 The important influence of transportation costs due 
to economic insecurity suggests that streamlining of laboratory testing procedures and 
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consistent delivery of multiple months of ART133 could be important systemic interventions to 
support engagement of resource-constrained PLHIV, such as FSWs. While previous research with 
FSWs has highlighted negative treatment by their HIV care providers,3,7 participants in this study 
reported generally positive experiences with these providers. Participants did, however, 
describe some experiences of discrimination within primary health care and breach of 
confidentiality by clinic staff. While sensitivity training for HIV clinic staff is an important 
intervention to improve engagement in care, it is not sufficient as PLHIV do not exclusively 
access health services within HIV clinics. It is, therefore, important that staff and providers in all 
health clinics understand how to appropriately provide services for FSWs and for PLHIV.  
Finally, economic resources- an important product of the broader sociopolitical context- and 
experience of stigma and discrimination at the structural level were influential. There is a clear 
need for stronger enforcement of existent HIV-related anti-discrimination laws in the DR to 
provide more economic opportunities for women living with HIV, particularly for women like 
Catalina who would like to find alternative employment. Additionally, poverty and associated 
food and transportation insecurity were critical barriers to engagement. Food incentives have 
been previously shown to increase engagement in HIV care in the Caribbean134 and may 
represent an important intervention strategy for economically insecure PLHIV.135 Finally, 
community and clinic-based HIV-related education and sensitization are essential to both reduce 
the further transmission of HIV and to create a more enabling environment for HIV care access 
among those already living with HIV.7 Efforts to address stigma must, however, address the 
multiple layers of stigma experienced by FSWs living with HIV in order to effectively reduce 
experienced and enacted stigma.53,56,98 
The experiences of FSWs described in this study resonate with research from the general PLHIV 
population, but there were some FSW-specific challenges along HIV care continuum associated 
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with FSWs’ social and economic context. Some of the challenges shared by FSWs in this study 
and PLHIV in previous research include post-diagnosis depression, lack of disclosure, costs 
associated with laboratory testing, costs of access to HIV services, ART side-effects and 
treatment collection and food insecurity.3,50,74,75,136 For example, a study among PLHIV in the DR 
found that suboptimal ART adherence was significantly association with heavy alcohol use, 
having children, and having less social support.74 Yet, FSWs face additional challenges related to 
the stigmatized nature of their work, the burden of double disclosure, their frequent financial 
insecurity and their irregular schedules, as has been noted in other settings.3,7,95 For example, 
FSWs in this study and others reported being blamed for their HIV infection due to stigma 
associated with HIV infection.56 This underscores the need for targeted interventions to address 
FSWs’ unique needs within HIV care. For example, FSWs may benefit from opportunities to 
strategize with HIV clinic counselors or clinicians on development of adherence techniques that 
are responsive to their irregular schedules and on disclosure of multiple, stigmatized identities. 
Many FSWs might also benefit from support in reducing alcohol and drug dependence. 
There are several important limitations to the present study. First, this study included 
individuals who were known by the study team or peers to be FSWs living with HIV, which may 
have resulted in a study population with higher engagement in HIV care. Second, this study was 
conducted by a research institute based within a hospital setting which may have influenced 
participants’ discussion of negative experiences within clinical services. To try to address this, 
field workers received considerable training and participants were interviewed on two occasions 
to increase rapport and openness. Finally, interviews were conducted over a relatively short 
period of time. Longitudinal, mixed methods research with PLHIV as they move along the 
continuum would be invaluable. 
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In conclusion, this study found that individual, interpersonal, environmental and structural 
factors were important influences on engagement in HIV care among FSWs throughout the HIV 
care continuum. While many of these factors have been noted in studies within the general 
population living with HIV, the economic instability and compounded stigma of being both HIV-
infected and a sex worker introduced additional barriers to engagement for FSWs. This 
underscores the need for the provision of psychological, social and economic support within a 
health system environment tailored to the needs of FSWs in order to maximize individual and 
public health. 
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Chapter 5. High drop-off along the HIV care continuum and 






To describe the HIV care continuum among female sex workers (FSWs) and to determine factors 
associated with experience of antiretroviral therapy (ART) interruption. 
Methods: 
A quantitative, cross-sectional survey was conducted with 268 FSWs living with HIV in Santo 
Domingo, Dominican Republic. FSWs were asked about their engagement in HIV care, 
sociodemographic characteristics and sex work (SW) context. We describe the treatment 
cascade in this population and identify factors associated with experience of ART interruption 
using multiple logistic regression. 
Results: 
FSWs living with HIV were lost at each step of the HIV care continuum with highest drop-off 
after initiation onto ART. Most participants linked to HIV care (92%), attended HIV services in 
the past six months (85%) and were initiated onto ART (78%), but discontinuation of treatment 
and irregular adherence were frequent. Only 48% of participants had an undetectable HIV viral 
load. A total of 36% of the participants ever initiated onto ART reported lifetime experience with 
an interruption of ART. The odds of ART interruption were 3.24 times higher among women who 
experienced SW-related discrimination (95% confidence interval [CI]: 1.28, 8.20), 2.41 times 
higher among women who reported ever using any drug (95% CI: 1.09, 5.34) and 2.35 times 
higher among women who worked in a SW establishment (95% CI: 1.20, 4.60). Self-stigmatizing 
beliefs related to SW were associated with higher odds of interruption as each additional point 
on the SW self-stigma scale was associated with a 9% increase in the odds of interruption (95% 
CI: 1.02, 1.16). Positive perceptions of HIV providers were protective as each additional point on 
the perception of HIV provider scale was associated with a 9% reduction in the odds of ART 
interruption (95% CI: 0.85, 0.98).  
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Conclusions: 
FSWs living with HIV confront barriers throughout the HIV care continuum resulting in low levels 
of HIV viral suppression. Given the clear importance in minimizing drop-off along the continuum 
and maximizing the potential benefits of ART, there is an urgent need for multi-level 
interventions to help support FSWs throughout the HIV care continuum.  
 
KEY WORDS 
HIV/AIDS; Treatment cascade; Continuum of care; Female sex workers; Antiretroviral therapy; 
Breakage in Care; Retention; Engagement  
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Introduction 
There has been a dramatic increase in the number of individuals receiving antiretroviral therapy 
(ART) globally,23 but people living with HIV (PLHIV) are lost throughout the HIV care 
continuum.31,32 The steps along this continuum include HIV testing, HIV diagnosis, linkage to HIV 
care, determination of ART eligibility, retention in pre-ART care, ART initiation, retention in ART 
care, adherence to ART and HIV viral suppression.25,28,29,36 These losses throughout the 
continuum are critical as the individual and public health benefits of ART, such as reduced 
morbidity, mortality and transmission, are well-established.12,13 Optimal engagement 
throughout the continuum, including adherence to ART, among individuals who are sexually 
active is an important mechanism for preventing the transmission of HIV.13,15,16,137  
The depiction of the HIV care continuum has provided a striking representation of the poor state 
of engagement in HIV care36 in the US26,37 and globally.25,38 By describing losses at each step, the 
continuum highlights challenges that compromise the effectiveness of HIV prevention and care 
strategies. The continuum also serves as a mechanism to better understand the state of 
treatment and prevention41 within specific sub-populations.42-44 Given the clear societal benefits 
of ART for prevention of HIV transmission,13 it is particularly important to understand the state 
of engagement in HIV care among individuals who are currently living with HIV, aware of their 
HIV status and sexually active, as they are most relevant sub-population for treatment as 
prevention.15,16  
There is growing recognition of the challenges faced by PLHIV throughout the HIV care 
continuum, but evidence is lacking on the experiences of FSWs.2,3 FSWs are disproportionately 
affected by HIV around the world and have 13.5 times higher odds of HIV infection than other 
women of reproductive age.1 FSWs confront heightened vulnerability not only to HIV infection, 
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but also to social, economic and systemic barriers to HIV care6,138 and have sub-optimal 
engagement.3,7,8 FSWs living with HIV also experience layers of stigma and discrimination related 
to each of their stigmatized identities.2,53,97,98 Stigma is a social process that reinforces 
differences and perpetuates existent inequities.53 A recent qualitative exploration of the 
experiences of FSWs in the Dominican Republic noted important influences of individual, 
interpersonal, environmental and structural factors throughout the continuum of HIV care 
(Chapter 4). No known study has, however, quantitatively documented the experiences of FSWs 
along the HIV care continuum, highlighting a critical gap in our understanding of the state of HIV 
treatment and prevention among FSWs. 
This study describes the HIV care continuum among FSWs living with HIV in the Dominican 
Republic, a country with a concentrated HIV epidemic.105 Previous research has documented 
considerable movement in and out of HIV care among FSWs in the Dominican Republic (Chapter 
4). Additionally, analysis of factors associated with detectable HIV viral load among the present 
study population noted the critical association between ART interruption and viral load.2 Taking 
into account this important relationship, this analysis also determined factors associated with 
experience of ART interruption.  
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Methods 
Trained female field workers administered a baseline, quantitative survey with all members of 
the Abriendo Puertas (AP; Opening Doors) cohort from November 2012- February 2013. This 
paper survey included questions on individual, interpersonal, environmental and structural 
factors related to HIV prevention, care, and treatment. The AP cohort included 268 FSWs who 
were living with HIV in Santo Domingo, Dominican Republic. The cohort has previously been 
described.2 All members of the AP cohort were female adults who had exchanged sex for money 
in the month preceding enrolment. HIV-positive serostatus was confirmed prior to study 
enrolment and participants were recruited using a hybrid sampling approach through peer 
referrals, existent relationships with the study team, and referrals from HIV clinics.  
All cohort members provided oral, informed consent and received $10 for completion of the 
baseline survey. This study was approved by the Institutional Review Boards of the Johns 
Hopkins Bloomberg School of Public Health and the Instituto Dermatalógico y Cirugia de Piel Dr. 
Humberto Bogart Diaz.  
Measures 
This paper describes the baseline HIV care continuum among AP cohort members. The 
definitions of each of the steps of the HIV care continuum, as self-reported by study participants 
or determined through laboratory testing, are described in Table 5.1. 
  
    
 73 
 
Table 5.1 Definitions of the steps within the HIV care continuum  
HIV diagnosed 
All participants had HIV-positive status 
confirmed using the Retrocheck rapid HIV 
test 
 Currently on ART 
Participant reported currently taking ART 
Linked to care 
Participant reported ever having attended 
HIV services 
 Adherent to ART 
Adherence to ART was determined through 
the AIDS Clinical Trials Group measures 
which included questions on 4-day 
adherence, adherence to specified ART 
intervals and to treatment instructions139 
Stayed in HIV care 
Participant reported having attended HIV 
services in the past six months  
 Undetectable Viral Load 
Participant baseline viral load, as determined 
through polymerase chain reaction testing, 
was less than 50 cells per cubic milliliter  
Initiated onto ART 
Participant reported having ever taken ART 
 Treatment Interruption 
Participant reported having ever stopped or 
suspended taking ART  
 
Independent Variables 
Independent variables of interest in the analysis of factors associated with ART interruption 
including, participant sociodemographic characteristics (e.g. age, household composition, 
income), clinical experiences (e.g. concurrent health conditions, perceptions of health status, 
HIV services and health providers) and sex work (SW) context (e.g. venue, self-stigma, substance 
use). Women were categorized as establishment-based if they indicated that they had worked in 
a formal SW establishment (e.g. club, disco, bar, hotel, billiard hall) in the past three months, as 
compared to working exclusively on the street or through phone calls.  
The responses to all three scales included in this study were developed from responses to 
questions with Likert scales ranging from one (strongly disagree) to four (strongly agree). HIV-
related self-stigma was determined through eight questions that assessed participants’ level of 
agreement with statements, including “Having HIV makes you feel like a bad person” and “You 
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feel guilty because you have HIV”, as adapted from validated, reliable HIV stigma scales.123,124 
Principal components analysis suggested strong unidimensionality and the scale had high 
internal reliability (Cronbach’s alpha=0.87). Scores ranged from 8 to 32 with a median score of 
18. Participants who reported more self-stigmatizing attitudes related to HIV-status had higher 
scores.  
SW-related self-stigma was determined through the same eight questions used in the HIV scale, 
but with “SW” replacing “HIV”. The questions assessed participants’ level of agreement with a 
series of statements, including “You feel embarrassed to be a SW” and “You feel that you are 
not worth anything because you are a SW”. These questions were adapted from the 
aforementioned, validated HIV-related self stigma scales.123,124 The final eight question scale had 
one underlying factor and high reliability (Cronbach’s alpha=0.88). Scores ranged from 8 to 32 
with a median score of 18. Participants with more self-stigmatizing attitudes related to SW had 
higher scores.  
Participants’ perception of HIV service providers was determined through ten questions that 
assessed participants’ level of agreement with statements, including “Your doctor is well trained 
to take care of medical problems like yours”, and “You feel respected by your doctor”. These 
questions were adapted from the validated Patients Reactions Assessment scale.119 Eight 
participants did not respond to these questions and were excluded from this part of the 
analysis. The scale was refined through iterated principal factor analysis and two questions were 
ultimately dropped from the scale to enhance its internal consistency. Scores ranged from 8 to 
32 with a median of 26. The final, eight question scale had very high reliability with a Cronbach’s 
alpha of 0.95. Participants with more positive perceptions of HIV service providers had higher 
scores.  
    
 75 
Participants were categorized as having experienced discrimination in the clinic related to their 
HIV-status if they indicated that they had ever received poor services, been denied medical 
attention or heard health personnel gossiping about them because they are living with HIV, as 
adapted from Baral et al.120 They were categorized as having experienced discrimination in the 
clinic related to their SW status if they indicated that they had ever received poor services, been 
denied medical attention or heard health personnel gossiping about them because they 
exchange sex for money. 
Dependent variable 
The key dependent variable of interest was history of ART interruption among women ever 
initiated onto ART. 
Analysis 
Survey data were analyzed using Stata 12.1.122 Participant responses were explored through 
histograms, scatterplots and descriptive statistics. These responses formed the basis of the 
description of the HIV care continuum. Baseline characteristics of study participants with and 
without reported ART interruption were then compared through bivariate analysis, using 
Pearson’s Chi-square tests and two-sided t-tests, as appropriate. Simple logistic regression (SLR) 
examining factors associated with ART interruption was conducted with significant independent 
variables from bivariate analysis. Multiple logistic regression (MLR) models were constructed 
using a forward stepwise approach. Starting with a null model, variables with p<0.10 in SLR were 
added to the model until the best model was constructed, as determined by comparison of log 
likelihood ratios and Akaike Information Criterion score (AIC). Additional variables were added 
to the model until the lowest AIC was obtained, while maintaining parsimony of model. The final 
model was checked and the model was determined to fit the data by the Hosmer-Lemeshow 
goodness-of-fit test (p=0.70).  
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Results 
The 268 study participants had a median age of 36 years old (interquartile range [IQR]: 30,42). 
Participants had low levels of education (64% indicated only a primary level education), and 11% 
had moved in the past twelve months, as shown in Appendix B. Nearly all (96%) of participants 
had disclosed their HIV status to someone and 61% described their health status as good or 
better, rather than fair or worse. A total of 43% of participants worked in a SW establishment in 
the past three months and participants had been engaged in SW for a median of 15 years (IQR: 
8, 21). Participants reported generally positive perceptions of HIV care providers (median score: 
26, IQR: 24, 31), but 29% and 15% reported experience of HIV-related or SW-related 
discrimination in the clinic, respectively. A quarter of participants reported ever using any drug 
and 60% reported alcohol use in the past month. Additionally, participants described self-
stigmatizing beliefs related to their HIV status (median: 18; IQR: 14, 21) and to their SW status 
(median: 18; IQR: 14, 22). 
HIV care continuum 
There was drop off among the 268 FSWs living with HIV at each step of the HIV care continuum, 
as shown in Figure 5.1.  
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Figure 5.1 HIV care continuum among female sex workers living with HIV in 
Santo Domingo, Dominican Republic (n=268) 
 
HIV diagnosis 
All 268 study participants were diagnosed with HIV. The median year of HIV diagnosis was 2008 
(interquartile range [IQR]: 2005, 2010). The primary motivations to test reported were 
pregnancy (27%) and perceived risk for HIV (21%). Less than half (43%) of participants received 
pre-test counseling and three-quarters (76%) reportedly received post-test counseling. 
Linkage to HIV care 
Almost all participants (92%) reported ever receiving medical attention related to HIV, most 
(61%) of whom had a medical check-up within one month of diagnosis. Of the 22 participants 
who never linked to care, 18 (82%) indicated that they were thinking about starting HIV care in 
the next six months and 13 (59%) knew the location of an HIV clinic.  
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Retention in HIV care 
The majority (85%) of participants attended HIV services in the six months preceding the 
interview. 83 of these women who attended HIV services in the past six months (37%) had, 
however, missed at least one clinical appointment. The most frequently mentioned barriers to 
attending HIV care were cost of clinic attendance (39%), lack of transportation to clinic (39%), 
fear that others would learn her HIV status if a participant goes to the clinic (32%) and lack of 
HIV status disclosure (23%). 
Initiation onto ART 
The largest fall-off along the HIV care continuum was between treatment initiation and viral 
suppression. Most (78%) participants had ever been initiated onto ART, with 72% currently 
taking ART. Figure 5.2 provides greater detail on participant experiences between treatment 
initiation and viral suppression on treatment. A large proportion of participants ever initiated 
onto ART indicated experience with an interruption of ART at some point (36%). The median 
number of days off treatment was 30 days (IQR: 4-75). Most of these women (60 of 76) 
subsequently resumed ART, but 16 did not. The most frequently reported reasons for ART 
interruption among women currently on treatment were experience of side effects (32%), 
depression (8%) and personal problems (7%). The most commonly indicated reason for 
discontinuation of ART among the 16 no longer on treatment was experience of side-effects 
(38%).  
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Figure 5.2 HIV care continuum among female sex workers living with HIV in 
Santo Domingo, Dominican Republic with emphasis on experiences between ART initiation and  
viral suppression on ART (n=268) 
 
Adherence to ART 
Completion of all doses in the past 4 days was reported by 79% of the 194 women currently 
taking ART. Perfect adherence to specified ART intervals (e.g. every 8 hours) and treatment 
instructions (e.g. take with food) was lower at 63% and 64%, respectively. The main barriers to 
ART adherence in the past six months were being away from the house (22%) and forgetting 
(19%). 
Viral Suppression 
A total of 128 participants (48%) had a viral load less than 50 cells per a cubic milliliter and only 
60% of participants currently on ART had viral suppression. It has previously been shown that 
detectable viral load in this study population was associated with younger age, diagnosis in the 
last 5 years, current ART status and ever interruption of ART. The odds of having a detectable 
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viral load were 3.09 times higher in women who reported interruption of ART (95% confidence 
interval [CI]: 1.44-6.59).2 
Factors associated with ART interruption  
Given the high prevalence of treatment interruption and its important association with viral 
suppression, we conducted further analysis of the factors associated with report of ART 
interruption. Table 5.2 shows that in SLR, younger age, having moved in the last 12 months, 
worse perceptions of HIV service providers, experience of SW-related discrimination in the 
clinic, lifetime use of any drug, work in a SW establishment and report of self-stigmatizing 
beliefs related to HIV and to SW were all significantly associated with experience of ART 
interruption.  
The final MLR model show that the odds of ART interruption were 3.24 higher among women 
who experienced SW-related discrimination (95% CI: 1.28, 8.20), 2.41 times higher among 
women who reported ever using any drug (95% CI: 1.09, 5.34) and 2.35 times higher among 
women who worked in a SW establishment (95% CI: 1.20, 4.60). Self-stigmatizing beliefs related 
to SW were associated with higher odds of interruption as each additional point on the SW self-
stigma scale was associated with a 9% increase in odds of ART interruption (95% CI: 1.02, 1.16).  
Positive perceptions of HIV providers were protective with each additional point on the 
perception of HIV provider scale associated with a 9% reduction in odds of treatment 
interruption (95% CI: 0.85, 0.98). 
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Table 5.2 Factors associated with experience of a interruption of antiretroviral therapy (ART) among 
HIV-positive female sex workers who have ever been initiated onto ART in Santo Domingo (n=205) 
  Relative odds 
 




Age (years) 0.95** (0.92, 0.99)   
Moved cities in last 12 months 3.74** (1.42, 9.85) 2.74  (0.89, 8.42) 
ART initiation (year) 0.93 (0.85, 1.02)   
Disclosed HIV status  4.76 (0.58, 38.8)   
Health status- good or better 0.60 (0.34, 1.08)   
Perceptions of HIV service 
provider scale 
0.89** (0.84, 0.95) 0.91** (0.85, 0.98) 
HIV-related discrimination in clinic  1.72 (0.93, 3.15)   
SW-related discrimination in clinic  3.99** (1.79, 8.89) 3.24** (1.28, 8.20) 
Sex Work context     
Time as SW (years) 0.97 (0.94, 1.01) 0.97 (0.93, 1.00) 
Lifetime use of any drug 2.96** (1.52, 5.80) 2.41* (1.09, 5.34) 
Establishment-based 2.15** (1.21, 3.81) 2.35** (1.20, 4.60) 
HIV self-stigma scale 1.10** (1.04, 1.16)   
SW self-stigma scale 1.08** (1.02, 1.14) 1.09** (1.02, 1.16) 
*p ≤0.05 **p ≤0.01 
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Discussion 
This study found that FSWs living with HIV were lost at each step of the HIV care continuum with 
particularly high drop-off after initiation onto ART. Most patients linked to HIV care (92%) and 
attended services in the past six months (85%), but participants reported considerable social, 
economic and health barriers at each step, as has been qualitatively described among a different 
group of FSWs living with HIV in the Dominican Republic (Chapter 4). The most frequently 
reported barriers to clinic attendance were cost- and transportation-related, but HIV status 
disclosure was also problematic. High levels of initiation onto ART were found, yet participants 
had considerable challenges with adherence and most drop-off was between initiation onto ART 
and viral suppression. Discontinuation of treatment and irregular adherence were frequent, 
likely contributing to the lower level of viral suppression (48%).  
Drop off along the continuum of care in this study population of FSWs in the Dominican Republic 
is considerably different from what has been described in previous research. US- and India-
based research among the general PLHIV population has determined that the high drop off 
during early steps in the continuum of HIV care drive the low rates of HIV suppression with 
nearly half of the loss occurring between linkage and retention in HIV care.26,36-38 In contrast, the 
present study determined that over half of all drop-off occurred between initiation onto ART 
and viral suppression. This underscores the continued relevance of focusing on participant 
experiences between ART initiation and viral suppression, as shown in Figure 5.2. This figure 
demonstrates that while a high percentage of participants were initiated onto ART, participants 
frequently experienced breaks in ART or lapses in adherence which may have compromised 
their treatment response. ART interruption, even amongst patients later reinitiated onto ART, is 
associated with an increase in opportunistic infections, increased HIV transmission and viral 
resistance to first-line therapy.136,140,141 Thus, the fact that 36% of participants reported 
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experience with ART interruption is troubling. Additionally, 40% of participants currently on ART 
had detectable viral load. It is possible that these previous treatment interruptions may have led 
to treatment resistance, resulting in a lower rate of viral suppression. This is an important 
finding given the important health and cost implications of development and transmission of 
resistant strains of HIV,70,137,142,143 particularly as all participants had engaged in sexual 
intercourse in the month preceding enrollment. 
Exploration of factors associated with ART interruption highlighted the importance of broader 
personal, interpersonal, environmental and structural context in influencing engagement in HIV 
care among FSWs, as described in Chapter 4. Participants’ report of positive perceptions of their 
HIV care providers was protective against breakage in care. This finding is consistent with 
previous research on the importance of providers’ attitudes and behaviors on engagement of 
PLHIV in HIV care.52,99 Yet this study found that participants experienced multiple layers of 
stigma and discrimination2,53,97 related to HIV-and SW-status that affected their engagement in 
HIV care. In addition to experiencing these layers, participants also reported experience of 
stigma at multiple levels ranging from internalized stigma (acceptance of negative perceptions 
related to PLHIV and oneself)56,144 to enacted discrimination within the clinic setting, as has been 
noted previously.3,56 The odds of reported treatment interruption were significantly higher 
amongst FSWs who described experiences of SW-related discrimination in a clinical setting, 
reported lifetime drug use, worked in a SW establishment and reported self-stigmatizing beliefs 
related to their SW occupation.  
This study demonstrated the important influence of SW context on engagement in care. The 
finding that work within a SW establishment was associated with treatment interruption was 
unexpected. This higher interruption may have been related to lower autonomy within 
establishments and the need for establishment-based SWs to hide their HIV status in order to 
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attract clients, prevent violence, and avoid getting fired. Additionally, establishment-based SWs 
may have had higher mobility as they switched establishments in response to HIV-status 
disclosure. It is possible that this broader economic and social instability may complicate 
sustained engagement and lead to treatment interruption. Of concern is the relatively frequent 
report of SW- and HIV-related discrimination within the clinical setting, as has been noted in 
prior research with FSWs.5,81 This underscores the importance of sensitivity training for clinicians 
in primary care clinics and HIV clinics on the appropriate provision of care for PLHIV and SWs.3,94 
Additionally, there is a clear need for future research to explore and disentangle the different 
layers and levels of stigma and discrimination experienced by FSWs living with HIV. 
Despite the large drop-off and the frequency of reported breakage in ART, this study found 
relatively high level of viral suppression, as compared to the prevalence within the US26,37 and 
India.38 This may in part be ascribed to potential selection bias within the study participants as 
all participants in this study were diagnosed, their status was known to at least the individual 
who recruited them to the study, and they were physical able to participate in data collection. 
Thus, this study population likely had higher linkage, retention, ART initiation and viral 
suppression than the broader target population of FSWs living with HIV in Santo Domingo.  
Scholarly and programmatic emphasis on the HIV care continuum can improve our 
understanding of and responsiveness to the local HIV epidemic,41 but there are some limitations 
in its conceptualization. Much of the emphasis has been on the population-level indicators at 
each discrete step along the continuum and the HIV care trajectory is often described as an 
almost linear path from diagnosis to viral suppression on ART. This conceptualization fails to 
acknowledge and account for the high movement of PLHIV in and out of HIV care, as has been 
shown in this study and previously31,32 and the important influence of engagement at one step 
of HIV care on subsequent engagement (Chapter 4). For example, previous experience of ART 
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interruption was significantly associated with current detectable viral load within this study 
population.2 This study was cross-sectional and cannot, therefore, identify factors that are 
predictive of breakage in ART. There is a clear need for prospective, longitudinal research on 
experiences as PLHIV move along and within the continuum of care within low-resource 
contexts in order to guide interventions and policies that minimize losses along the continuum.41 
Finally, this study is limited by its use of self-reported measurement of ART interruption due to 
the low feasibility of collecting these data from clinical records across the country. Despite these 
methodological limitations, this study provides important, new insight into the experiences of 
FSWs within HIV care and adds to our understanding of factors associated with ART interruption 
within this key population. 
In conclusion, this study showed that FSWs living with HIV were lost at each step of the HIV care 
continuum, particularly after initiation onto ART. Factors associated with ART interruption were 
at multiple levels including individual drug use and self-stigma, clinic-level experiences and the 
broader SW context. Given the clear importance in improving engagement in HIV care to 
maximize individual and public health, there is an urgent need for multi-level interventions to 
help support FSWs throughout the HIV care continuum.  
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Chapter 6. Retention in HIV care among female sex 
workers in the Dominican Republic: implications for 
research, policy and programming 
 
Abstract 
There are clear benefits from retention in HIV care, yet millions of people living with HIV, 
including female sex workers (FSWs), are not retained. This study described factors from 
Andersen’s Behavioral Model that were associated with retention in HIV care among FSWs using 
two measures of retention: a six-month measure of attendance at an HIV clinic and a measure 
that combined clinic attendance and missed visits. Quantitative surveys were conducted with 
268 FSWs living with HIV in the Dominican Republic. Participants linked to HIV care reported 
high rates (92%) of six month attendance, but 37% of these participants missed clinic 
appointments. Using the combined measure, the odds of being retained in HIV care were higher 
among participants with more positive perceptions of HIV service providers (adjusted relative 
odds [ARO]: 1.17; 95% confidence interval [CI]: 01.09, 1.25). Lower odds of retention were noted 
among women who reported recent alcohol consumption (ARO: 0.50; 95% CI: 0.28, 0.92) and 
among women with self-stigmatizing beliefs related to sex work (ARO: 0.93; 95% CI: 0.88, 0.98). 
The findings from this study support the hypothesis that retention in HIV care may be best 
determined through a combined measure as missed visits are an important mechanism to 
identify in-care patients who require additional support. Retention in HIV care was associated 
with enabling, health need, and vulnerability factors which represent important targets for 
future policy and programming. 
 
Key words 
HIV/AIDS; Female sex workers; Antiretroviral therapy; Retention; Engagement; Measurement 
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Introduction 
Retention in HIV care has considerable individual and societal benefits, including improved 
clinical outcomes, decreased transmission of HIV, reduced healthcare costs and increased access 
to antiretroviral therapy (ART).10,11 Access and adherence to ART, in turn, is strongly associated 
with reduced morbidity, mortality, and HIV transmission. 12,13 These clear benefits of ART have 
led to growing interest in the notion of “treatment as prevention” with people living with HIV 
(PLHIV).15 Yet millions of PLHIV do not access the HIV care that they require or are sub-optimally 
retained in care.23,36 Engagement in HIV care can be particularly challenging for vulnerable 
groups such as female sex workers (FSWs) who are disproportionately affected by HIV1,78 and 
confront stigma and other barriers to health services.4-6  
The likelihood of PLHIV linking to and being retained in HIV care is influenced by a variety of 
factors. According to Andersen’s Behavioral Model for Vulnerable Populations, health care 
access may be influenced by predisposing characteristics, existence of enabling resources, and 
the health need of individuals, all of which can be affected by membership in vulnerable groups 
such as FSWs.60-62,69 Predisposing characteristics- the propensity to use services- are comprised 
of demographic factors, social structure and health of the physical environment. Enabling 
resources are the personal, family and community resources available to use health care. These 
consist of both the accessibility of health services and an individual’s ability to use these 
services. Health need includes an individual’s perception of his/her own health state and the 
judgment by medical practitioners about his/her need for care.60,63,64 Previous applications of 
the Andersen model has shown that access to HIV care in the US was associated with ethnicity, 
gender, education, injection drug use, medical insurance coverage, concurrent health conditions 
and symptoms,68 along with age and waits for medical appointments.62 The model has not, 
however, been applied to look at which factors are most salient influences on engagement in 
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HIV care among FSWs, a group that faces unique barriers and facilitators within HIV care 
(chapters 4 and 5).  
Measuring engagement in HIV care 
There is growing interest in patients’ engagement in HIV care, but there are important 
methodological challenges in its measurement.145 Engagement in HIV care is understood to 
encompass both linkage to and retention in care.36 Linkage to HIV care is the binary construct of 
having ever attended HIV services, but there is no clear “gold standard” measurement of 
retention.30,45 Retention in HIV care has been measured in various ways, including missed visits, 
visit adherence, and treatment gaps. These measures include: counts of missed visits; 
dichotomous measure of missed visits; proportion of visit adherence; number of four-month-
long intervals in a year during which the patient had at least one kept visit; dichotomous 
measure of whether six months elapsed in between kept visits; and the Health Resources and 
Service Administration (HRSA) HIV/AIDS Bureau measure (dichotomous measure of whether 
there were at least two kept visits with a primary HIV medical provider that were at least 90 
days apart within the year).30,45 A recent study of the associations of the six aforementioned 
retention measurements with one-another and with HIV virological suppression in the United 
States found that there was considerable variation across the measures in their categorization 
of patients as retained with lowest retention (33%) using the perfect visit adherence and highest 
retention (77%) using the HRSA measure. Despite these differences, each of the measures was 
strongly and significantly associated with HIV virologic suppression. The authors concluded that 
retention measures should be selected based on the available data, the question of interest, and 
the study rationale.45 Best practice is to utilize multiple retention measures within one study, 
particularly one based on missed visits and another based on kept visits,45 yet no known study 
has used a measure that combined both missed visits and kept visits. There is a clear need for 
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further exploration or the association of these measurements, particularly in low-resource 
contexts. This study aims to contribute to the evidence on factors associated with retention in 
HIV care among a highly vulnerable group, FSWs in the Dominican Republic, using multiple 
retention measures.  
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Methods 
Study setting and participants 
We conducted a baseline, quantitative survey with the members of the Abriendo Puertas 
cohort. The cohort included 268 female sex workers living with HIV in Santo Domingo, 
Dominican Republic. The cohort has previously been described.2 All members of the cohort were 
female adults who had confirmed HIV-positive serostatus and who had exchanged sex for 
money in the month preceding completion of the baseline survey. Participants were recruited 
through peer referrals, existent relationships with the study team, and referral from HIV clinics.  
The study was approved by the Institutional Review Boards of the Johns Hopkins Bloomberg 
School of Public Health and the Instituto Dermatalógico y Cirugia de Piel Dr. Humberto Bogart 
Diaz in Santo Domingo. Cohort members provided oral informed consent to participate in the 
study.  
Measures 
This paper describes results from the baseline survey conducted with all cohort members 
between November 2012 and February 2013. Independent variables of interest, organized in 
this paper by Andersen’s Behavioral Model for Vulnerable Populations, included participants’ 
predisposing characteristics (e.g. age, household composition), enabling factors (e.g. perceived 
quality of services, experience of discrimination in the clinic, cost of transportation to clinic), 
perceived and evaluated health need, and vulnerability (e.g. duration of sex work [SW], self-
stigmatizing beliefs).  
The key dependent variable of interest was retention in HIV care. Retention was defined in two 
separate ways for the study. The first definition, “Attended”, categorized participants as 
retained if they reported attendance at an HIV clinic in the past six months. The six month 
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measure was selected for this study because it can be easily collected in operations research 
and is not affected by different clinical scheduling practices across clinics.30 The second 
definition, “Perfect attendance”, categorized participants as retained if they reported 
attendance at HIV services in the past six months and also reported that they did not miss any 
HIV service appointments in the past six months. This second measure included both a kept and 
a missed visit measure, as has been suggested as best practice.36 Participants who attended HIV 
services in the past six months, but also missed an appointment over the six months were 
differentially classified by the two definitions. 
The HIV service provider scale, HIV-related self-stigma scale, and SW-related self-stigma scale 
were all adapted from validated scales119,123,124 and have been previously described in Chapter 5. 
Higher scores on the HIV service provider scale were associated with more positive perceptions 
of providers and higher scores on the two self-stigma scales were associated with more self-
stigmatizing perceptions. All scales had high internal consistency (Cronbach’s alpha 0.87-0.95). 
Analysis 
Data were analyzed using Stata 12.1.122 During exploratory data analysis (EDA), the distribution 
of all dependent and independent variables of interest were described. Baseline characteristics 
of the study participants were explored through bivariate analysis, comparing those who were 
and were not categorized as retained in HIV services by each definition, using Pearson’s Chi-
square tests and two-sided ANOVA tests.  
Simple logistic regression (SLR) assessing factors associated with retention in HIV care was 
conducted with all independent variables from EDA that significantly differed amongst retention 
categories. Multiple logistic regression analyses were then conducted to assess the association 
of significant variables from SLR and a priori variables of interest with retention in care. During 
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model building, the log likelihood ratios were compared and the models with the lowest Akaike 
Information Criterion (AIC) score were selected. Additional variables were added to the model 
until the lowest AIC was obtained, while maintaining parsimony and fit of model. The final 
model was checked and there were no strong confounding relationships or collinearity between 
the included variables. The overall degree of fit was determined using the Hosmer-Lemeshow 
goodness-of-fit test (p=0.38). 
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Results 
Defining retention in care 
Of the 268 FSWs that completed the baseline survey, 246 (91.8%) had ever received HIV-related 
medical attention (i.e. were linked to HIV care). Of these 246 women, there was considerable 
variation in their categorization as retained or not by the two definitions. Using the “Attended” 
definition of having attended HIV services in the past six months, 227 (92.3%) of linked women 
were categorized as retained in care. A total of 83 (36.6%) of these women who attended HIV 
services in the past six months reported missing an HIV service appointment in the past six 
months. Thus, these women were defined as retained in HIV services using the “Attended” 
definition and were defined as not retained using the “Perfect attendance” definition. The 83 
women with differential categorizations attended an average of 3.8 appointments in the past six 
months, but all missed appointments. Only 144 (58.5%) of participants were categorized as 
retained in care by the “Perfect attendance” definition.  
Sociodemographic and clinical characteristics of the 246 women who were ever linked to care 
are shown in Table 6.1, stratified by retention status using the two different definitions of 
retention. In terms of sociodemographic factors, participants who were classified as not 
retained were less likely to be single and had more children. They were more likely to have 
experienced a sexually transmitted infection (STI) or STI symptoms in the past six months, had 
worse perceptions of their health status, HIV services and HIV service providers and reported 
more experiences of discrimination within health clinics. Women who were not retained were 
also more likely to have moved in the past 12 months and reported more substance use and 
self-stigmatizing perceptions.  
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Table 6.1 Sociodemographic and clinical characteristics of 246 female sex workers living with HIV in Santo Domingo by 
retention in HIV care status using two different definitions of retention in HIV care¹ 
  Not retained 
by either 
definition 
Retained by one or both 
definitions 
Total 







N 19 83 144 246 
Predisposing Sociodemographic Factors     
Age (years)- Median (interquartile range [IQR]) 37 (32, 42) 34 (29, 42) 36 (32, 43) 36 (30, 42) 
Single– n (%) 2 (10.5) 12 (14.5) 34 (23.6) 48 (19.5) 
Education– n (%)     
Primary 13 (68.4) 48 (58.5) 89 (63.6) 150 (62.2) 
Secondary 4 (21.1) 32 (39.0) 41 (29.3) 77 (32.0) 
University 2 (10.5) 2 (2.4) 10 (7.1) 14 (5.8) 
Lives alone– n (%) 1 (5.3) 16 (19.3) 16 (11.1) 33 (13.4) 
Number of children- Median (IQR) 3 (2, 5) 3 (2, 4) 3 (1, 3) 3 (2, 4) 
Health Need     








Previous tuberculosis infection- n (%)  1 (5.3) 9 (10.8) 16 (11.1) 26 (10.6) 
STI/ STI symptom in last 6 months- n (%) 12 (63.2) 49 (59.0) 61 (42.4) 122 (49.6) 
Perceived health status is good or better - n (%) 8 (42.1) 45 (54.2) 100 (69.4) 153 (62.2) 
Enabling Factors     
Disclosed HIV status - n (%) 17 (89.5) 82 (98.8) 138 (95.8) 237 (96.3) 
Has medical insurance- n (%) 10 (52.6) 48 (57.8) 86 (59.7) 144 (58.5) 
Perceived quality of HIV services– n (%)     
Excellent 6 (42.9) 28 (33.7) 52 (36.1) 86 (35.7) 
Very good 1 (7.1) 17 (20.5) 43 (29.9) 61 (25.3) 
Good 2 (14.3) 18 (21.7) 31 (21.5) 51 (21.2) 
Adequate 2 (14.3) 10 (12.1) 8 (5.6) 20 (8.3) 
Poor 3 (21.4) 10 (12.1) 10 (6.9) 23 (9.5) 
Perceptions of HIV service provider scale- Median (IQR)³ 24 (20, 25) 24 (24, 28) 29 (24, 32) 26 (24, 31) 
Travel time to clinic (minutes) - Median (IQR) 60 (30, 90) 60 (30, 90) 60 (30, 90) 60 (30, 90) 
Roundtrip travel cost to clinic (US dollars) - Median (IQR) 3 (2, 5) 3 (2, 4) 3 (2, 4) 3 (2, 4) 
Experience of HIV-related discrimination in clinic- n (%)  11 (57.9) 26 (31.3) 36 (25.0) 73 (29.7) 
Experience of FSW-related discrimination in clinic- n (%)  9 (47.4) 9 (10.8) 17 (11.8) 35 (14.2) 
Vulnerability     
Age when started TRSX (years)- Median (IQR) 19 (16, 20) 18 (15, 25) 19 (15, 25) 19 (15, 24) 
Duration as TRSX (years)- Median (IQR) 20 (12, 23) 14 (6, 20) 15 (8, 21) 15 (8, 22) 
Moved cities in last 12 months- n (%) 3 (15.8) 12 (14.5) 10 (6.9) 25 (10.2) 










Use of any drug in last 6 months- n (%) 2 (10.5) 9 (10.8) 6 (4.2) 17 (6.9) 
Alcohol consumption in last month- n (%)  11 (57.9) 58 (69.9) 76 (52.8) 145 (58.9) 
HIV self-stigma scale score- Median (IQR) 17 (14, 25) 18 (14, 22) 17 (13, 20) 18 (14, 21) 
FSW self-stigma scale score- Median (IQR) 21 (14, 22) 19 (16, 22) 17 (13, 20) 18 (14, 22) 
¹Participants were categorized as retained in the “Attended” definition if they attended HIV services in the past six months. Participants 
were categorized as retained in the “Perfect attendance” definition if they attended HIV services in the past six months and did not miss 
any appointments 
² These participants were differentially classified by the definitions because they attended HIV services in the past six months, but missed at 
least one appointment 
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For the 246 participants who were linked to care, the “Attended” measure was not significantly 
associated with viral suppression (p= 0.09). The “Perfect attendance” measure was significantly 
associated with viral suppression (p<0.01) and, therefore, most closely associated with the 
biologic and public health outcome of interest. Thus, the retention measure which combined 
clinic attendance and missed visits was utilized for subsequent analysis. 
Factors associated with retention in care 
SLR of the factors associated with retention in HIV care among FSWs living with HIV using the 
“Perfect attendance” definition are shown in Table 6.2. The odds of retention were significantly 
higher if participants reported good or better health status, as compared to those with fair or 
bad health (relative odds [RO]: 2.10; 95% confidence interval [CI]: 1.24, 3.56) and had more 
positive perceptions of their HIV care provider (RO: 1.17; 95% CI: 1.10, 1.25). The odds of 
retention were significantly lower among participants who had an STI or STI symptom in the 
past six months (RO: 0.49; 95% CI: 0.29, 0.83), consumed alcohol in the last month (RO: 0.53; 
95% CI: 0.32, 0.91) or reported more self-stigmatizing beliefs related to SW (RO: 0.93; 95% CI: 
0.89, 0.98). 
The final model demonstrated that each additional point on the HIV service provider scale was 
associated with a 17% increase in the odds of retention (adjusted RO [ARO]: 1.17; 95% CI: 01.09, 
1.25). The odds of being retained were 50% lower in women who reported alcohol consumption 
in the last month (ARO: 0.50; 95% CI: 0.28, 0.92). Finally, each additional point on the FSW-




    
 96 
Table 6.2 Factors associated with retention in HIV care, defined as having attended HIV care in the past six 
months and not missed any appointments, among female sex workers living with HIV in Santo Domingo 
(n=238) 
  Relative odds 
 





    
Age (years) 1.02 (0.99, 1.05)   
Single  1.94 (0.98, 3.84)   
Number of children 0.87 (0.74, 1.03)   
Health Need     
Health status- Good or better 2.10* (1.24, 3.56) 1.79 (0.98, 3.27) 
STI/ STI symptom in last 6 
months 
0.49* (0.29, 0.83)   
Enabling Factors     
Perceived quality of HIV services     
Excellent Ref -   
Very good 1.56 (0.78, 3.14)   
Good 1.01  (0.50, 2.06)   
Adequate 0.44 (0.16, 1.18)   
Poor 0.50 (0.19, 1.28)   
Perceptions of HIV service 
provider scale  
1.17** (1.10, 1.25) 1.17** (1.09, 1.25) 
HIV discrimination in clinic  0.59 (0.34, 1.02)   
FSW discrimination in clinic  0.62 (0.30, 1.28)   
Vulnerability     
Age when started TRSX (years) 1.02 (0.99, 1.06)   
Moved cities in last 12 months  0.43 (0.19, 1.01) 0.41 (0.15, 1.13) 
Use of any drug in last 6 months 0.36 (0.13, 1.01)   
Alcohol consumption in last 
month 
0.53* (0.32, 0.91) 0.50* (0.28, 0.92) 
HIV self-stigma scale 0.96 (0.91, 1.01)   
FSW self-stigma scale 0.93** (0.89,0.98) 0.93** (0.88, 0.98) 
*p ≤0.05 **p ≤0.01 
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Discussion 
FSWs living with HIV in this study population in the Dominican Republic had high rates of six 
month attendance in HIV services, but participants frequently reported missing clinic 
appointments. There was considerable variation in the categorization of the same individuals as 
retained or not, depending on the retention measure used. 45 A total of 92% of linked FSWs 
living with HIV were retained in HIV care based on a six month measure of attendance at HIV 
clinic, but only 59% were categorized as retained when retention was defined as six month HIV 
clinic attendance with no missed visits. Within this study population, the measure that included 
missed visits better identified individuals who were from a broader social and clinical context 
that complicated retention in HIV care (high mobility, substance use, self-stigmatizing 
perceptions and negative experiences within HIV care). The combined measure was also more 
closely associated with evaluated health outcomes, as shown by its significant association with 
HIV viral suppression. The finding that the different retention measures resulted in vastly 
different portrayals of the state of engagement in HIV care among FSWs underscores the 
important influence of measure selection and the need for standardization across studies. 
Comparison of the measures in this study supports the hypothesis that retention in HIV care is 
best measured through kept and missed visit measures within one study.45  
The finding that the inclusion of missed visits within the definition of retention is closely 
associated with viral suppression has important methodological and practical implications. It 
underscores the importance of documenting both HIV clinic attendance and HIV clinic missed 
visits within research on the HIV care continuum in order to better understand factors that may 
ultimately compromise engagement. This is particularly important as missed visits are 
associated with poorer health outcomes47,121,146 and may indicate lower attention or concern for 
one’s own health, as has previously been suggested.146 Vulnerable populations such as FSWs 
    
 98 
often come from a context of broader social and economic instability that can lead to missed 
visits and slower treatment response.99,147 These findings suggest that HIV care providers and 
services would benefit from checking whether in-care patients are missing visits as these missed 
visits may be indicative of a broader context that could lead to non-retention in HIV care or sub-
optimal treatment response,148 particularly among FSWs. In a sense, missed visits are a “canary 
in the mine” that can serve as a mechanism to identify patients who require additional 
support.121,148 
This study found that retention in HIV care among FSWs was associated with health need, 
enabling and vulnerability factors, as described by Andersen and colleagues.62,63,69 FSWs in this 
study who perceived themselves as healthy and had existent enabling resources in the form of 
positive perceptions of HIV service providers were more likely to be retained in HIV care. The 
important influence of perceived health need and perceptions of HIV providers on engagement 
has previously been noted.3,7,68 Yet FSWs’ retention was also influenced by their vulnerability 
with lower odds of retention among women reporting substance use and more self-stigmatizing 
beliefs related to SW. The lower retention associated with self-stigmatizing beliefs related to SW 
highlights an important way in which the experiences of FSWs with HIV care may be different 
from other PLHIV. Additionally, the important relationship between alcohol consumption and 
engagement in HIV care among FSWs found in this study has been previously described in 
qualitative research.7 Previous research has shown the importance of predisposing attributes 
like marital status on access to HIV care,62,68 but none of these variables were significantly 
associated with retention among FSWs. It is possible that FSWs face broader personal, social and 
systemic challenges that supersede the importance of predisposing factors. While the high 
prevalence of missed visits is troubling, all of the factors associated with retention in HIV care 
among FSWs in this Dominican population can be modified through public health policy and 
    
 99 
programming. Specifically, retention in HIV care among FSWs could be improved through 
provision of support for FSWs to decrease alcohol consumption and reduce self-stigma related 
to SW, along with sensitivity training of health care providers. 
This study has some important limitations related to its design and implementation. All 
participants knew their HIV status and their status was also known to either a peer or clinic staff 
member which likely biased the study towards inclusion of patients with higher engagement in 
HIV care. Additionally, participants were not randomly sampled and this paper reports on cross-
sectional, self-reported data. Participants self-report of retention status may have led to social 
desirability bias, but verification of retention through clinical records at the more than 20 
different clinics attended by study participants was not feasible. Finally, participants were not 
asked if they had missed a visit in the past six months if they had not attended a visit in the past 
six months, making it impossible to directly compare the combined measure with a missed visit 
only measure. Despite these limitations, this study contributes to the evidence on measurement 
of retention in HIV care using a combined measure and on factors associated with retention 
among FSWs. 
In conclusion, this study demonstrated the value of including both clinic attendance and missed 
visits in the measurement of retention in HIV services among FSWs. Missed visits were indicative 
of a broader social, economic and community context confronted by FSWs that complicated 
engagement in HIV care. Retention in HIV care among FSWs was associated with not drinking 
alcohol, reporting better perceptions of HIV providers and possessing lower self-stigma related 
to sex work. These factors represent important, mutable targets for future public health policy 
and programming to improve retention in HIV care among FSWs. 
  
    
 100 
Chapter 7. Discussion 
This dissertation described three analyses of the experiences of FSWs living with HIV along the 
HIV care continuum. Despite using different methodological techniques, the dissertation 
presents consistent findings related to FSWs’ engagement and disengagement in HIV care. 
Previous research with the general PLHIV population in the US has demonstrated that PLHIV 
temporarily or permanently disengage in HIV care throughout the HIV care continuum.28,30-33,125 
This dissertation described a similar process amongst FSWs within the DR. These findings 
provide important insights into the pathways in and out of care. The dissertation also highlights 
important influences on FSWs’ engagement at multiple levels and compares these influences to 
those experienced by the general PLHIV population. This discussion briefly reviews these 
findings and offers suggestions for future research, policy and programming related to 
engagement in HIV care among FSWs living with HIV.  
Negotiating Engagement 
Engagement in HIV care was not a static construct for FSWs as participants continually 
negotiated engagement within a broader context of structural constraints and social conditions. 
Health care providers and the health system expected FSWs to take their treatment multiple 
times a day and to regularly attend HIV services. Yet HIV care was not experienced by FSWs in a 
vacuum as participants were frequently forced to weigh the benefits of this HIV care against a 
multitude of barriers. FSWs in the qualitative study confronted a range of challenges which 
included lack of transportation money, insufficient food, hungry children, undisclosed HIV and 
SW statuses, internalized and enacted stigma related to both their HIV status and their SW in 
their homes, communities and clinics, competition from FSW peers for clients and mental 
distress. There were, therefore, days, weeks and years in which participants were unable or 
unwilling to prioritize their HIV care over these competing demands. As a result, FSWs 
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frequently moved in and out of care over time, as shown in the quantitative description of the 
HIV care continuum among FSWs in the DR. In contrast to other populations,26,36-38 the largest 
losses from care among FSWs living with HIV in the DR were after ART initiation. It is possible 
that many of the barriers to engagement in HIV care described in the qualitative strand are 
particularly problematic for FSWs who are expected to adhere to ART multiple times a day. 
Influences on Engagement in HIV Care 
By describing disengagement at each step, the depictions of the HIV care continuum among 
FSWs living with HIV highlighted challenges that compromise the effectiveness of HIV 
prevention and care strategies in the DR. This dissertation identified important individual-, 
interpersonal-, environmental- and structural-level factors which influenced engagement in HIV 
care. All three analyses highlighted the important role of individual-level factors such as mental 
and physical health on engagement. An important influence on mental health is self-stigma 
related to both HIV and to SW. Previous research has indicated that stigma affects engagement 
in HIV care in diverse ways, including delaying access to HIV testing, limiting disclosure of HIV 
status, increasing rejection of PLHIV by sexual partners, family and social networks, and 
generating reluctance to be seen taking treatment or attending an HIV clinic, 49,57,58 as was 
frequently noted within the qualitative analysis. This dissertation adds to the evidence base by 
quantitatively examining internalized and enacted stigma associated with multiple identities: 
being HIV-infected and being a sex worker. While there is layering of this stigma,53 self-stigma 
related to SW emerged as a more significant influence on retention in HIV care and ART 
interruption amongst this study population. This interesting finding warrants further 
examination to disentangle the ways in which stigmatized identities influence one-another and 
to explore reasons why one identity may be more salient. It also demonstrates the importance 
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of provision of counseling and mental health services that are tailored to meet the unique needs 
of individuals with multiple stigmatized identities. 
Interpersonal factors such as disclosure of HIV status and access to emotional and economic 
support were also important influences on engagement in HIV care. FSWs in the qualitative 
analysis described various ways in which relationships with family, friends, peers, and HIV care 
providers helped them to surmount financial, emotional, environmental and structural barriers 
to care. Disclosure and perceived psychosocial support were not, however, significantly 
associated with engagement in HIV care within the quantitative analyses. This lack of association 
may be due to the very high level of HIV status disclosure of study participants and the fact that 
all participants had existent relationships with peers or the study team which facilitated their 
recruitment.  
At the environmental level, FSWs were generally happy with the services of their HIV providers, 
but participants described considerable other challenges within the health system. In the 
qualitative analysis, participants mentioned the important role of providers throughout the 
continuum. FSWs described how HIV care providers gave them emotional and tangible support 
in the form of food, money, telephonic availability and treatment delivery. Within the 
quantitative analysis participants also indicated generally positive perceptions of the providers. 
These positive perceptions were protective against ART interruption and were associated with 
higher odds of retention in HIV care. These findings support previous research that emphasizes 
the important influence of HIV care providers on engagement in HIV care. 52,99 
Despite these positive relationships with HIV providers, FSWs described numerous frustrations 
with the health system that impeded engagement. These included systemic delays in HIV 
diagnosis, CD4 enumeration and ART initiation. Of concern, participants frequently described 
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experiences of discrimination within health services in both study phases. In the qualitative 
analysis these negative experiences were often followed by disengagement. Within the 
quantitative analysis, participants reported generally positive perceptions of their HIV clinics 
(82% described their HIV services as good or better), but indicated frequent negative 
experiences within the broader health system. Over one-quarter of participants reported 
experiences of HIV-related discrimination in clinics and 15% reported discrimination related to 
their SW. Across quantitative analyses, this experience of discrimination in clinics related to SW 
was significantly associated with sub-optimal engagement in HIV care. Additionally, involuntary 
disclosure of HIV status by health care providers was noted among qualitative participants. Prior 
work has frequently called for sensitivity training of HIV clinic staff.3,6,7 The findings from this 
dissertation, however, emphasize the need to include staff and providers from both HIV-specific 
and general health clinics within these trainings in order to reduce discrimination and facilitate 
continued engagement in care. 
Structural factors such as access to economic resources, stigma and discrimination and the 
broader SW context also affected engagement of FSWs in HIV care. Within the qualitative 
analysis, participants commonly described how lack of money for transportation, food, CD4 
testing, vitamins and medication complicated engagement. Similarly, the most frequently 
mentioned barriers to attending HIV care described by quantitative participants were the costs 
of attendance and lack of transportation. It is interesting to note, however, that income and cost 
of transportation to HIV clinic were comparable amongst participants who were retained and 
not retained in care. It is possible that these costs were challenging for all FSWs living with HIV 
and that all participants confronted competing demands for their scarce resources, but 
participants who attended their appointments prioritized their HIV care more than those who 
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missed visits or experienced ART interruption. Future research should explore the influence of 
both perceived and actual HIV care costs in greater detail. 
Factors associated with engagement in HIV care among FSWs in this dissertation are similar to 
those identified in research within the general PLHIV population, but there were some FSW-
specific challenges. FSWs faced additional challenges related to the stigmatized nature of their 
work, the burden of double disclosure, their frequent financial insecurity and their irregular 
schedules, as has been noted in other settings.3,7,95 Additionally, previous research and this 
dissertation have shown the detrimental impact of the frequent association of sex work with 
alcohol and drug use among FSWs living with HIV.7,99 For example, some participants in the 
qualitative phase described how they would avoid taking ART on nights when they were 
engaging in SW because of their alcohol consumption. Substance use was also high amongst 
FSWs included in the quantitative phase with 60% of respondents reporting alcohol 
consumption in the past month and nearly one quarter indicating lifetime drug use. A form of 
substance use was significantly associated with engagement in each of the quantitative 
analyses: there were higher odds of ART interruption amongst FSWs who reported lifetime drug 
use and there were lower odds of retention in HIV care amongst FSWs who indicated alcohol 
consumption in the last month. This substance use was also significantly associated with having 
an STI.2 In light of the high prevalence of substance use in FSWs living with HIV and its significant 
association with HIV service and biological outcomes, integration of substance use services 
within HIV care for FSWs2 is an important component of efforts to enhance FSWs’ engagement 
in HIV care. 
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Implications for Research, Policy and Programming 
Findings from this dissertation have important implications for future research, policy and 
programming. There is a clear need for further mixed methods and longitudinal research on 
engagement in HIV care, particularly amongst FSWs and other key populations in low-resource 
settings. As indicated by the analysis on retention in HIV care, such studies should include both 
clinic attendance and missed visit measures of retention. Studies on experiences on ART and of 
viral suppression would also benefit from inclusion of measures of experience of ART 
interruption as this may have important implications for treatment response. Finally, studies 
that involve SWs living with HIV should include distinct measures and questions on stigma 
associated with SW and stigma associated with living with HIV in order to enhance our 
understanding of the relationships between these multiple identities and their association with 
engagement.   
Relevant to public health policy, this dissertation documented frequent violation of the rights of 
FSWs living with HIV in the DR, along with systemic barriers to optimal engagement in HIV care. 
Participants described considerable discrimination within their homes, communities, health 
services and work. The DR has passed legislation that protects the human rights and dignity of 
PLHIV, 110 but these laws are not sufficiently enforced. For example, PLHIV in this study and 
previous research have described pervasive HIV testing prior to employment and termination of 
employment upon discovery of HIV-positive status.57,97,103 FSWs also described numerous 
experiences with discrimination, including in health services. There is a clear need for stronger 
enforcement of existent legislation in the DR to create enabling environments in which FSWs 
can meet their PHDP needs. Additionally, participants described considerable barriers within the 
design of HIV services in the DR which inhibited engagement such as the provision of HIV 
services and laboratory services in distinct locations. Engagement of economically insecure 
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populations such as many of the FSWs participants from this study would likely improve if CD4 
enumeration was conducted within HIV services. Policies supportive of consistent delivery of 
multiple months of ART also warrant further consideration.  
Finally, findings from this study have important implications for programming to enhance 
engagement in HIV care among FSWs. This study highlighted important barriers and enablers of 
HIV care. Recognition of these barriers such as substance use and missed clinical visits amongst 
in-care patients can serve as an early warning system for HIV care providers to help them 
provide additional support for PLHIV before they disengage from care. In order to be effective, 
this support must address the multiple levels of barriers experienced by FSWs living with HIV. 
Multi-level interventions, such as the AP intervention,which include individual counseling, peer 
navigation, HIV care provider training and community mobilization,2 are likely to be most 
effective in meeting the unique needs of FSWs living with HIV. Such interventions should be 
incorporated into existent health services and scaled up to optimize engagement in HIV care for 
all FSWs living with HIV in the DR.  
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Strengths and Limitations 
This dissertation represents a novel contribution to the scientific evidence on engagement along 
the HIV care continuum among a highly vulnerable population, FSWs, but it has important 
strengths and limitations. The mixed methods design and relatively large sample size facilitated 
in-depth and generalizable exploration of participants’ experiences. Within the qualitative 
phase, multiple data collection and analytic techniques were utilized and participants were 
interviewed on two occasions to allow for a more nuanced understanding of engagement in HIV 
care. The quantitative phase utilized validated scales which demonstrated high internal 
reliability, along with multiple measures of retention in HIV care. Additionally, the highly skilled 
local implementation team and the strong relationships between the study team and the study 
population facilitated a rigorous and appropriate application of both study phases.  
This dissertation does, however, have some important limitations, including potential bias and 
limitations inherent in the study design. The first limitation to the study is in the selection of 
participants. The quantitative study included over 45% of the approximately 600 FSWs living 
with HIV in Santo Domingo (3.0% HIV prevalence in 20,000 FSWs), but it is probable that the 
included women were not representative of the source population because they were aware of 
their HIV status and their status was known to the study team or a peer. Thus, these women 
likely had higher engagement with HIV care than the broader population of FSW living with HIV 
in Santo Domingo. A second limitation of the qualitative and quantitative strands was potential 
social desirability bias. The interviews took place at the HVRU office which is located in a 
hospital setting. It is, therefore, possible that participants reported more favorable experiences 
with health services. One additional limitation of the study is that engagement with health 
services was assessed through self-report and, therefore, may have been affected by 
information bias in the form of recall bias or social desirability bias. Efforts were made to 
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minimize this bias through establishment of comfortable, open interview environments and 
through use of clear time references within questions, but actual attendance at health services 
was not measured due to logistical, ethical and feasibility considerations. Finally, data from the 
quantitative phase were collected at one point in time, limiting the understanding of how 
participants’ engagement changed over time. This underscores the need for longitudinal, mixed 
methods exploration of engagement in HIV care among PLHIV. 
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Chapter 8. Conclusion 
This study found that individual, interpersonal, environmental and structural factors were 
important influences on engagement in HIV care among FSWs throughout the HIV care 
continuum. Many of these factors have been identified in studies within the general population 
living with HIV. However, this mixed methods dissertation demonstrated that the compounded 
stigma of living with HIV and being a sex worker and the nature of SW introduced additional 
barriers to engagement for FSWs. These SW-specific barriers resulted in missed visits and 
disengagement in HIV care throughout the HIV care continuum. Given the clear importance in 
improving engagement in HIV care to maximize individual and public health, there is an urgent 
need for multi-level interventions to help support FSWs throughout the HIV care continuum.  
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Appendix A. Narratives of the experiences of FSWs living with HIV 




Carmen was diagnosed with HIV two years ago 
after she felt ill. She was initially linked to care, 
but never returned to collect her CD4 count 
results and has left care. 
Sofia was diagnosed about one year ago at a 
mobile testing unit. She has never attended HIV 
services. 
Isabella was diagnosed at a mobile testing unit 
eight months ago. She is not attending HIV 
services. 
Individual Carmen decided to test for HIV because she was 
feeling sick and she had family and partners who 
had died from AIDS. Carmen is religious and draws 
strength from her relationship with God.  
Sofia was surprised and depressed by her HIV-
positive diagnosis. She has never attended HIV 
services because “I am embarrassed to go”. 
Isabella was initially depressed when diagnosed, 
but she has come to terms with her status. She 
feels well and thinks that she might get sicker if 
she attends HIV services. She does not know 
about ART or CD4 counts. 
Interpersonal Carmen has close friends who are living with HIV 
that have motivated her. She has not, however, 
told anyone else her status. Her three children 
probably suspect it, though, because of 
community gossip.  
Sofia has a strong relationship with a peer 
navigator who helps her and provides her with 
medication. She is the only one who knows her 
HIV status. She explains that she cannot access 
support because of this lack of disclosure, “If I say 
to my partner, I say to my brother, ‘help me’ they 
are going to ask me, “Why? What do you have 
that you feel bad?” 
Isabella came to terms with her diagnosis by 
thinking of her children. “my sister was who 
helped me the most. She was who always gave me 
encouragement” and reminded Isabella that she 
needed to live to take care of her children. 
Isabella’s mother, a peer navigator and her sister 
know her status and provide her with support. 
Her mother, however, treats her differently, 
“They are afraid of me because it seems as though 
[HIV] spreads easily” and prefers that she does 
not cook. She also cleans up after her with bleach. 
She has not disclosed her HIV status to her 
partners or children. 
Environmental Carmen was given her HIV test results by a peer 
counselor at which time, “I wanted to go crazy 
and he told me, ‘look. I have been positive for 
eleven years’ and we spoke and we always speak 
on the phone. I always call him from my work and 
when I feel bad I go there and he gives me a 
vitamin and he gives me money so that I can eat… 
And if he can live, why can’t I?”  
Carmen has attended HIV services and went to 
the national laboratory for CD4 count analysis, but 
has not collected her results because she did not 
have money. She has not returned to the doctor 
since because the doctor will require her CD4 
Sofia received pre-test counseling and was given 
her test results two hours after testing at a mobile 
unit. She felt the team that tested her treated her 
very well. 
Isabella was provided her test results ten minutes 
after testing at a mobile unit. She was very happy 
with the quality of care provided by the testers 
who treated her well. 
While Isabella is not in HIV services, she has heard 
about long lines, expensive ART and drug stock-
outs.  
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count results to start her on treatment. 
Structural Carmen lost 60 pounds so many people in her 
community say that she is sick. 
Her biggest ongoing challenge is poverty and a 
lack of food. 
Sofia did not describe experiences of stigma and 
discrimination. 
Isabela has not attended services because “I think 
that the people will realize that I have the illness 
and sometimes you arrive at places and the 
people keep looking at you.” 
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Elena was diagnosed during pregnancy. She is 
moderately retained in care, but has not initiated 
onto ART. 
Sandra was diagnosed by mobile testing unit. She 
was previously linked to care, but is not currently 
attending HIV services. 
Beatriz was diagnosed during pregnancy in 1999. 
She is currently on ART, but has had breaks in 
engagement in HIV services.  
Individual Elena tested for HIV during pregnancy. At the 
time, she had only ever been with one partner 
and she was shocked. She was also depressed 
when her child was diagnosed as HIV-positive 
Elena sometimes misses her own or her child’s 
appointments because she does not have money 
for transportation. 
Sandra was very depressed and tried to hang 
herself after her HIV diagnosis. 
Sandra is not currently in care because she feels 
well and does “not have any symptom that alerts 
me that I have to go and get checked. If one day I 
fall ill, then I will go to get checked.” She is still 
depressed and feels as though she is sinning by 
engaging in sex work as a person living with HIV 
because it is killing and “one of God’s 
commandments is not to kill”.  
When Beatriz was diagnosed, she wanted to die. 
Now on ART, Beatriz sometimes feels like quitting 
because she does not like taking pills. She 
generally takes her treatment, but “sometimes 
there are days when one has her mind on so many 
things. Sometimes there is a lot going on in the 
house that I have to wash and I forget.” 
Interpersonal  Sandra has not disclosed her HIV status to friends, 
partners or family. “Sometimes I want to scream 
the truth, but if I do it I think I will lose both 
[partners] because not everyone is used to having 
an HIV-positive partner.” Involvement in an NGO 
support group for PLHIV helped make Sandra feel 
a bit better after she was diagnosed. 
The support of friends was instrumental in Beatriz 
coming to terms with her HIV status. None of 
Beatriz’s four children know her HIV her sex work 
status and no one knows that she is on ART. She 
went to a support group for four months, but 
grew tired of it because she did not receive any of 
the money that they collected. 
Environmental Despite being referred to care at diagnosis, Elena 
delayed until her aunt, a nurse, brought her to 
care. In health services she explained, “There are 
people in the hospitals that treat you at a bit of a 
distance once they learn you are [HIV-positive].” 
Within her HIV clinic, however, Elena feels she is 
treated well and treat her with kindness and like 
family. 
She is, however, frustrated by the long delays and 
lack of available medications. 
Sandra had previously tested negative when she 
tested positive at a mobile testing unit. She did 
not receive pre-test counseling, but she received 
counselling with her diagnosis.  
She later attended HIV services for 2-3 months, 
but became frustrated by the long lines and being 
forced to go to so many places. Despite the waits, 
she felt that the care providers in the HIV clinic 
were very good. 
Beatriz was told to test for HIV when she was five 
months pregnant. They first told her that the test 
was damaged and re-tested her, delaying her 
diagnosis by about 10 days. “When they told me 
what I had I left running like a madwoman. They 
grabbed me and I started to yell, to shout out and 
the doctor began to hug me and console me… I 
was reflecting and I found myself in the hands of a 
friend, that she was my friend, my confidante, my 
everything. She has helped me a lot and has given 
me a lot of advice.” Beatriz attended HIV services, 
but was frustrated that they only gave 
prescriptions and not the actual medications 
other than ART.  
Structural A nurse disclosed Elena’s HIV status in her Sandra was referred to care, but “the truth is that Beatriz experienced discriminatory care at the 
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community. Elena’s entire community knows she 
has HIV and discriminated against her and her 
children. 
when they gave me all of this advise I said yes, but 
later I did not take care of myself because I was 
afraid that people would know that I live with the 
illness. Because nowadays people discriminate 
against one for being a sex worker or also if one is 
HIV-infected.” 
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Luciana was tested after feeling ill in 1998. She 
began ART in 2004 and now has reached viral 
suppression on treatment. 
Maria was diagnosed after feeling ill in 2000. She 
started ART the same year. She left treatment for 
a period, but is now on a second-line ART 
regimen. 
Alma was diagnosed in 2008 after she and her 
partner became ill. She is on ART, but has poor 
adherence. 
Individual When diagnosed, Luciana was worried that her 
partner and child would test positive and was 
relieved that they did not. She draws strength 
from her relationship with God and feels well. “I 
feel good and healthy and I say thanks to God for 
this and to the doctors and these medicines that 
have helped me that, thank God, my viral load is 
undetectable.” While she sometimes lacks money 
to get treatment, she is supported by nurses. She 
has come to terms with living with HIV and is 
thankful that she has been able to meet many 
friends and projects. She does, however, see the 
need to attend clinic appointments is a barrier for 
employment. 
Maria was motivated to test because she had lost 
over 50 pounds. Although her CD4 count was 
okay, Maria insisted on starting treatment 
because of the weight loss. Despite the doctor’s 
warning that the treatment was life-long, Maria 
ran out of moneyand defaulted from treatment.  
Maria has been re-initiated onto second line 
therapy, but still struggles with adherence. She 
has gone up to five days without taking treatment 
and they are probably going to change her 
regimen again. She knows that this will be her last 
possible regimen and that regimen changes are 
caused by not taking treatment.  
Alma was motivated to test because she heard 
that her partner had AIDS and she felt sick for two 
years. She was worried that she had cancer and 
went to an oncologist. Alma was relieved to have 
HIV, “I prefer to have AIDS, it is less rare [than 
cancer].” Alma was very angry and decided to kill 
her partner, but later decided that it was not 
worth going to jail. She is now on treatment and 
feels that she is a healthy woman. Sometimes she 
grows tired of daily ART, though, and decides that 
she will not take any of her treatment. When she 
goes up to a week without taking ART it is 
because “I forget, I get tired of taking many pills”.  
Interpersonal Luciana has disclosed her HIV status to most of 
her family, including her children. She is a 
member of a support group in the clinic, “I receive 
a lot of love, a lot of kindness from the group.” 
She has a large group of friends that she met 
through the group, but many of them have died. 
When they die, “I feel really upset. I feel 
melancholy. You feel that they were your friend 
and more than your friends, your sisters because 
in reality it is the same blood that runs through 
our veins.” 
Maria was with her brother when her HIV-positive 
diagnosis was confirmed. He has helped her a lot, 
but her family is less supportive, “they do not 
discriminate against me but it is not normal 
either… If I come to the doctor and they tell me 
something I speak with [my brother] and I say, 
‘look. This is happening to me’ or ‘I feel in such a 
way’”. Maria has not told her children that she 
has HIV, but they see her take her treatment and 
remind her when she misses it. 
She has also received support from a peer 
navigator. She attended a support group for a 
while, but she grew tired of it. 
Alma came to terms with her diagnosis by 
thinking of her friends who had HIV, “I have a 
friend who has had AIDS for 15 years… then I said, 
fine, if she is living, why can’t I live?” 
Alma has told all of her family her HIV status and 
many of her friends, but not her boyfriend of two 
years. Her family and friends treat her well and 
provide her with some financial support when she 
needs it. 
Alma has a good relationship with a peer 
navigator who told her where to go when she was 
diagnosed. Alma has attended a support group at 
a church where members are occasionally given 
money. 
Environmental Luciana did not receive any pre- or post-test 
counseling. She was initially told that her test was 
damaged, “but I knew this little trick”. Her HIV-
positive test results were given to her cousin. 
Luciana initially experienced side-effects on 
Maria did not receive any pre-test counseling, but 
she was referred to HIV care when she tested 
positive. Maria was treated well when she was 
diagnosed. 
Maria has been happy with the care she receives 
When Alma tested for HIV, the oncology clinic 
called her daughter and told her that Alma’s test 
was damaged. Alma went to the clinic, but they 
would not give her the HIV test results. The clinic 
then told her daughter that Alma had HIV.  
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treatment, but the doctors switched her regimen 
and she feels better. She is very happy with the 
care that she receives in the ARV clinic and feels 
she is treated with love and kindness. “Sometimes 
I do not have money to come and look for [ART] in 
the HIV clinic and I call one of the nurses that 
works here, ‘Look. I only have tonight’s [ART] left 
and I cannot come to look for it tomorrow because 
I do not have money. Do me a favor and bring it to 
me… And thank God that she supports me. And 
she makes me get it.” 
from clinicians, but she developed drug-resistance 
from defaulting treatment after being unable to 
pay for private care. Despite financial problems, 
“the doctor who attends me told me that ‘when 
you don’t have money you come with what you 
have and I will help you. I will not abandon you.” 
Maria did not want to have to look for money 
each month so she switched to a public clinic 
where the doctor “is very good. He helped me a 
lot” and helped switch her to an effective 
regimen. 
Alma receives good care at her clinic, but the 
doctor sometimes gets mad at her when she 
forgets her ART. She has missed treatment various 
times, including collecting it 15 days late.  
Structural Luciana did not describe experiences of stigma 
and discrimination. 
Many people in Maria’s community gossiped 
about her when she lost weight. A neighbor of 
hers also called Maria’s partner and told him that 
Maria had AIDS. Maria has also been gossiped 
about at her local shop. Additionally, she has been 
sent away from a non-HIV doctor who did not 
want to perform an operation on her. One of 
Maria’s biggest barriers to ART adherence is lack 
of food. 
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Mariana tested positive in 1998 after her partner 
became sick and tested HIV- positive. She has 
been on ART since 2005 and is adherent. 
Gabriela tested positive in 2004 after she lost 
weight. She has been on ART since 2008, but is 
only moderately adherent. 
Agustina was diagnosed in 2005 while pregnant. 
She began ART the same year and takes her 
treatment every day. 
Individual Mariana was very depressed when she tested 
positive and had little knowledge of HIV. She later 
felt better and went to trainings about HIV. She is 
not paid for her work as a home visitor to PLHIV, 
but she is fulfilled by it. 
Gabriela tested for HIV after giving birth. She had 
already been breastfeeding and her child died of 
HIV when he was one year old. 
Agustina was very depressed when she was first 
diagnosed. She later became involved with a 
network of FSWs. She now takes her treatment 
every day, although she takes it at different time, 
depending on if she is working. 
Interpersonal Mariana’s partner knew her status and also had 
HIV, but he later died. She was, depressed, but 
then met a peer navigator who connected her to 
support groups. She later trained to work with 
PLHIV and provide support to others. 
Mariana has disclosed her HIV status and sex work 
status to her two children. Mariana’s daughter 
helped her to stay adherent when she had terrible 
side-effects during her first weeks on ART “there 
was a moment when I said I am not going to take 
them. I got up and my daughter was my great 
accomplice… my daughter was in charge of giving 
me the pill”. Her daughter still sometimes calls to 
remind her to take her ART. 
Her children’s father has, however, provided her 
with invaluable support and told her “you are not 
alone. You can count on me. This word is very 
valuable when someone tells you this.”  
She continues to have economic challenges and 
cannot always afford to have laboratory tests 
done. 
Gabriela’s parents know her HIV status, but not 
her daughters. She has only told one friend who 
also has HIV, but many people know her status 
because they saw her when she was very ill. Her 
parents are very supportive of her and she has a 
close relationship with her mother who knows 
about her sex work.  
A peer navigator and network of FSWs have been 
very important in Agustina accepting her HIV 
status, “They are my support and later they have 
sustained me, they have given me strength and I 
have continued ahead.” She has also learned a lot 
about HIV from the organization. 
Agustina has other friends who are FSWs living 
with HIV and they help one-another and loan each 
other money and treatment. Agustina was also 
connected to a psychologist through her peer 
navigator who helped her understand that she is 
not going to die soon and “this is nothing, that 
this is like any other illness and what I have to do 
is take care of myself.” 
In addition to these friends, Agustina’s mother, 
partner, and pastor know that she is positive, but 
her children do not. Her husband works to 
support her and her children, but there have been 
some difficult times like when he was laid off. 
When this happened, Agustina’s friends gave her 
money “to go to collect my treatment and 
sometimes I did not have transport money and 
they gave it to me.”  
Environmental Mariana’s partner tested positive for HIV, but no 
one gave them counseling or explained what that 
meant. Mariana paid to be tested for HIV at the 
lab after her partner tested positive. The person 
who tested her put two gloves on each hand and a 
mask. The doctors first told her that her test was 
Gabriela was instructed to test for HIV in 2004 
after she had post-partum stomach problems. She 
experienced a delay in getting her result because 
the doctor, “told me no, we will not give [the 
results] to you. You have to look for your mom or 
dad.” She went crying to get her mother, but the 
Agustinga was diagnosed in 2006 when pregnant. 
They did not tell her that she was positive when 
she tested at 2-3 months gestation, but she was 
sent to get medicine. She tested for HIV again at 7 
months and tested positive. “When you are 
pregnant they do all of the tests, then when they 
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damaged. Mariana went to the hospital and lied 
she was her sister and said that she was collecting 
Mariana’s results. They gave her a stapled paper 
that she opened when she got home and it said 
reactive. “They never gave me a talk or told me, 
what was HIV? What was AIDS?” 
Mariana delayed attending HIV services, but is 
now very happy with her clinic. She works as a 
peer educator in the clinic and started ART in 
2005. Initially she had horrible side effects, “you 
have to understand the importance of the 
medications because if not you can get to a point 
when you have been taking them for two weeks 
and you say ‘I am not going to take them 
anymore.” The side-effects subsides and Mariana 
takes her treatment well. The only challenge she 
had was when there was an ART shortage and she 
was only given 15 days of ART instead of 2 
months. This cost a lot in transportation. 
doctor was gone when they arrived at the clinic. It 
was a Friday so on Monday her father went to get 
the result. Her father told her that it was 
something of the stomach and that she had to go 
somewhere they would cure her. She was brought 
to an HIV clinic to meet with a psychologist. She 
saw many signs about HIV and she asked he dad, 
“do I have this? And he said no. Don’t worry. They 
are going to cure you.” The psychologist told her 
she was HIV-positive and provided her with 
counseling.  
Gabriela attended HIV services and later started 
ART in 2008 when her CD4 count was 47. She is 
still on ART, but she sometimes goes to bed 
without remembering to take her treatment.  
did the analysis I was positive, but the doctor did 
not want to tell me anything. He told me to come 
here [to HIV clinic]” where she received a 
prescription for medicine.  
When she was at the hospital to give birth, she 
was discriminated against. Agustina was sent to 
many different clinics post-partum. She would 
arrive somewhere and they would send her to a 
different clinic. A friend finally introduced her to a 
peer navigator who brought her to an HIV clinic.  
Agustina is really happy with the care that she 
receives in the HIV clinic and she has an 
undetectable viral load on treatment. It is, 
however, frustrating when they sometimes are 
low on treatment and only give one month 
supplies since it costs the same amount to get less 
treatment. Additionally, Agustina has to pay to 
see the doctor and for medications. 
Societal Mariana was discriminated against by her mother 
and sisters who would not let her spend time with 
her nephews. Her mother told many people in the 
community that Mariana had AIDS and was dying. 
Mariana educated them and their relationship has 
improved. 
Gabriela’s neighbors learned her status when she 
was very sick and many of them have 
discriminated against her. 
Agustina did not describe experiences with stigma 
and discrimination. 
 




Ana Sofia was diagnosed with HIV in 1996 when she was pregnant. She 
attended HIV services and was initiated onto treatment in 2009, but quit in 
2010. She is not longer attending HIV care. 
Fernanda was diagnosed in 2003 when she was pregnant. She is now in HIV 
care and on ART. 
Individual Ana Sofia was diagnosed when she was 7 months pregnant. At the time, she 
did not know what HIV was, “When she told me that I had the virus I said, what 
was that, the HIV virus, AIDS?” She prayed that her baby would be born 
negative, but the child was not.  
Fernanda was depressed and suicidal after her HIV diagnosis as a teenager. 
She gave birth to her baby who was HIV-negative, but the baby died after 
ten days which left her very depressed. 
Interpersonal Ana Sofia did not tell her family her HIV status, but her sister figured it out and 
told her family. Her daughters know that she has HIV, but not that she is a 
FSW. Her partner at the time of diagnosis knew that he had infected her and 
Fernanda was with her nephew when she received her HIV test result. She 
went to go jump from a bridge, but could not leave him, “If it were not for 
him I think that I would be dead now because I was determined to throw 
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they stayed together for 11 more years. 
Ana Sofia has a good relationship with a peer navigator and actively 
participates in a support group for FSWs living with HIV. 
myself from a bridge.”  
Later, she was brought by two peer navigators to HIV service. The navigators 
treat her well. There is, however, a lot of competition with other FSWs. 
Fernanda has also told her entire family and many friends her HIV status. 
She is a part of a support group at her clinic.  
Environmental Ana Sofia tested positive when she was pregnant. She had previously tested 
negative when required to test by her employer at a sex establishment. She 
did not receive pre-test counseling and was given her result by the secretary, 
along with a letter to give the doctors when she was in labor. She gave the 
letter to the doctors, but they did not pay attention to it and she gave birth 
vaginally without precautions.  
Ana Sofia was not provided with a referral for herself, but was given one for 
her daughter. She was later brought to a clinic by a peer navigator. Ana Sofia 
was initiated onto ART in 2009 and remained on treatment for one year. She 
complained that they often just gave prescriptions instead of the medication, 
“You still go to the doctor and there is not a pill to give you, there never is; they 
give you a prescription so that you buy it because they never have even 
acetaminophen to give you.” She later stopped attending because the clinic 
staff did not help her to deal with side effects. She was dizzy and had blisters 
on her skin, but they did not change her regimen so she thought, “fine, if you 
are not going to change [my ART regimen] I am not going to keep coming.” 
Fernanda was seven months pregnant when the doctor sent her to do tests. 
She received pre-test counseling, but was then made to take three HIV tests, 
going back and forth to the clinic. She was then told that she did not have 
anything, but that she had to come to the clinic with her mother. She had 
another friend have the same thing happen to her who ended up having HIV 
so Fernanda said to the doctor, “If I have AIDS, tell me” and the doctor told 
her that she had HIV. She received counseling that was good, “they spoke to 
me well, they treated me well” 
She delivered through a cesarean section. When she was in the hospital 
recuperating the staff treated her very well and brought her food from 
outside of the hospital. They said her daughter was negative and that she 
could take her home, but she became ill and was brought back to the 
hospital where she died. She later was brought to an HIV clinic and started 
treatment. Initially, she had many side-effects when she first started 
treatment like dizziness, diarrhea, but after five months this passed.  
 
Structural Ana Sofia’s partner wanted to kill the woman who he believed infected him, 
but she was beaten by another man who she infected. Maribel’s partner’s 
family initially blamed her for his diagnosis “because they that that since I am 
in the street [a FSW], they thought that it was me, being in the street, that it 
was me who infected him”, but later realized it was not her who infected the 
man. Ana Maria frequently hears people gossiping about her HIV status and 
they ask her if it is true that she has HIV and she tells them that it is. 
Ana Sofia struggles has encountered many structural barriers to ART 
adherence, “I left treatment because I did not have adequate food to take that 
medication and it was very potent and I said, ‘they still give me the medication. 
And with what, at least, with what am I going to nourish ”. Additionally, it was 
difficult to take ART when she was drinking alcohol with work, “you are in 
business, taking medication, having mala noche [nights out as a FSW]. It is not 
obligatory, but sometimes you have to drink drinks for the power to do things. I 
had to quit it when I through myself back on the streets, I had to quit it.” 
Fernanda confronts considerable stigma related to her HIV status. She has 
been blamed by her exes’ family, “they hate me because they think I killed 
their child, I said to her that what killed was the sickness, it wasn’t me.” She 
does not tell her sexual partners because, “they will kill me. They speak very 
poorly about people with HIV”. 
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Alejandra was diagnosed in 2003 when her partner was sick. She did not 
attend HIV services and became very ill and later tested positive again while 
pregnant.  
Emilia was diagnosed with HIV in 2006. She has not attended health services 
in more than two years and is not on treatment. 
Individual Alejandra was very depressed when she learned her status, “I arrived at my 
house and threw myself on the floor and it gave me depression.” She later 
became depressed again when the father of her daughter died.  
Now on treatment, Alejandra still sometimes has side-effects like nausea 
and pain, but she continues to take her treatment. 
Emilia has been very depressed and suicidal. Emilia does not think about her 
HIV infection and continues to lead a normal life, “I say that this illness is 
mental…this health condition… for me it is mental”. Rather than going to the 
clinic, Emilia said, “I take vitamins, I eat well. I have never had a crisis, never. 
I have never had the necessity.” She is, however, very active in various 
activities related to HIV like rapid testing on the beach and giving out 
brochures. She has a lot of books and brochures about HIV like nutrition and 
treatment. 
Interpersonal Alejandra decided to test for HIV because her partner was sick and another 
partner gave her money to test.  
Alejandra accessed HIV care with the help of a peer navigator who made her 
a clinic appointment and paid for her transportation. She also has been a 
member of a support group for a long time which makes her feel better and 
“explains that this [HIV] is nothing, because there are a lot of people that 
have it, that have it and do not know”. 
Many people in her community know her HIV status, including her family 
who she has told so that they hear it from her instead of from others. Her 
children do not know, but she thinks that the older daughter might because 
she brings Alejandra her ART.  
Emilia tested for HIV after her partner tested positive. He accused Emilia of 
infecting him and threatened to kill her. Emilia’s partner also told her entire 
family that she had HIV and they subsequently ended their relationship. 
Someone saw Emilia crying outside of the clinic when she was diagnosed and 
they helped her to understand, “I would have gone to kill [my partner].If I 
had not gotten this educator, I don’t know where… I would have been 
imprisoned a long time ago.” In addition to this support, Emilia’s sister and 
daughter have helped her and know her HIV status, “I wanted to die in that 
moment I had depression, I wanted to die, but my sister helped me and told 
me that no, that I am going to get up and everything was going to continue 
normally.” Emilia has also participated in many support groups. 
Environmental Alejandra first tested positive in 2003, but she did not attend HIV services. 
She became pregnant and tested positive again. She had a c-section and 
they gave her daughter treatment. They sent a psychologist to her when she 
was in the hospital post-partum. She entered HIV care, but later left when 
she became convinced by a fake doctor that he had a cure for HIV. 
Alejandra later returned to care and was initiated onto treatment. She 
initially experienced a lot of side-effects such as dizziness and fever and had 
her regimen switched. Alejandra now has an undetectable viral load and she 
is very happy with the care that she receives, “because if someone comes 
with a problem, once they look for a psychologist for you, she immediately 
leaves what she is doing and attends to one, you see, they bring you help.” 
After her diagnosis, Emilia attended HIV services, but she has not returned 
because she saw many people that she knows at the clinic. 
Structural Many people in Alejandra’s community know her HIV status because it was 
disclosed by a hospital nurse. They also could tell because, “people when 
they see someone lose weight it is AIDS, not one is going to think she has 
cancer.” 
Emilia had her HIV status disclosed at her local salon by a woman who 
worked in the laboratory where she was tested. Many people know that she 
has HIV because of the activities she participates in and have told others. 
 
 
Appendix B. Sociodemographic and clinical characteristics of 
268 female sex workers living with HIV in Santo Domingo 
in the Abriendo Puertas cohort 
 Table B.1 Sociodemographic and clinical characteristics of 268 female sex workers 
living with HIV in Santo Domingo in the Abriendo Puertas cohort 
N 268 
Predisposing Sociodemographic Factors  
Age (years)- Median (interquartile range [IQR]) 36 (30, 42) 
Single– n (%) 51 (19.0) 
Education– n (%)  
Primary 167 (63.7) 
Secondary 81 (30.9) 
University 14 (5.3) 
Lives alone– n (%) 34 (12.7) 
Number of children- Median (IQR) 3 (2, 4) 
Health Need  
Positive test (year) - Median (IQR) 2008 (2005, 2010) 
Previous tuberculosis infection- n (%)  26 (9.7) 
STI/ STI symptom in last 6 months- n (%) 134 (50.0) 
Perceived health status is good or better - n (%) 164 (61.2) 
Enabling Factors  
Disclosed HIV status - n (%) 257 (95.9) 
Has medical insurance- n (%) 153 (57.1) 
Perceived quality of HIV services– n (%)  
Excellent 86 (35.4) 
Very good 62 (25.5) 
Good 52 (21.4) 
Adequate 20 (8.2) 
Poor 23 (9.5) 
Perceptions of HIV service provider scale- Median (IQR)³ 26 (24, 31) 
Travel time to clinic (minutes) - Median (IQR) 60 (30, 90) 
Roundtrip travel cost to clinic (US dollars) - Median (IQR) 2.5 (1.5, 3.8)  
Experience of HIV-related discrimination in clinic- n (%)  77 (28.7) 
Experience of FSW-related discrimination in clinic- n (%)  40 (14.9) 
Vulnerability  
Age when started TRSX (years)- Median (IQR) 18 (15, 24) 
Duration as TRSX (years)- Median (IQR) 15 (8, 21) 
Establishment-based SW- n(%) 114 (42.5) 
Moved cities in last 12 months- n (%) 29 (10.8) 




Use of any drug in last 6 months- n (%) 22 (8.2) 
Lifetime use of any drug- n (%) 65 (24.3) 
Alcohol consumption in last month- n (%)  161 (60.1) 
HIV self-stigma scale score- Median (IQR) 18 (14, 21) 
FSW self-stigma scale score- Median (IQR) 18 (14, 22) 
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